<?xml version="1.0" encoding="UTF-8"?>
<projectSnippetsTree>
 <snippetsTree>
  <snippets file="./PMC3427559/results/search/virus_topics/results.xml">
   <result pre="original work is properly cited. rstb20110354.pdf Abstract There are 219" exact="virus" post="species that are known to be able to infect"/>
   <result pre="The first of these to be discovered was yellow fever" exact="virus" post="in 1901, and three to four new species are"/>
   <result pre="that there is still a substantial pool of undiscovered human" exact="virus" post="species, although an apparent slow-down in the rate of"/>
   <result pre="1. Introduction Following on from the discovery of tobacco mosaic" exact="virus" post="in 1892 and foot-and-mouth disease virus in 1898, the"/>
   <result pre="discovery of tobacco mosaic virus in 1892 and foot-and-mouth disease" exact="virus" post="in 1898, the first ‘filterable agent’ to be discovered"/>
   <result pre="‘filterable agent’ to be discovered in humans was yellow fever" exact="virus" post="in 1901 [ 1]. New species of human virus"/>
   <result pre="fever virus in 1901 [ 1]. New species of human" exact="virus" post="are still being identified, at a rate of three"/>
   <result pre="ranging from the rare and mild illness due to Menangle" exact="virus" post="to the devastating public health impact of HIV-1. In"/>
   <result pre="interested in all stages of the process by which a" exact="virus" post="shifts from not infecting humans at all to becoming"/>
   <result pre="or even months. Of course, not all newly identified human" exact="virus" post="species are ‘new’ in the sense that they have"/>
   <result pre="starting point for attempts to characterize and interpret patterns of" exact="virus" post="diversity. 2. Virus diversity and discovery (a) Survey of"/>
   <result pre="and including 2005 for reports of human infection with recognized" exact="virus" post="species, using species as defined by the International Committee"/>
   <result pre="was often lacking. We obtained a list of 219 ICTV-recognized" exact="virus" post="species that have been reported to infect humans. 23"/>
   <result pre="virus species that have been reported to infect humans. 23" exact="virus" post="families were represented by species in this list. (b)"/>
   <result pre="a delimited habitat for viruses. The discovery curve for human" exact="virus" post="species is shown in figure 1 a. Figure 1."/>
   <result pre="invested in detecting new viruses; (iii) the ‘visibility’ of different" exact="virus" post="species, e.g. as a function of how common they"/>
   <result pre="of different virus species, e.g. as a function of how" exact="common" post="they are and the nature of any disease caused;"/>
   <result pre="they are and the nature of any disease caused; (iv)" exact="virus" post="taxonomy and the rules for designating a ‘species’; (v)"/>
   <result pre="rules for designating a ‘species’; (v) the emergence of new" exact="virus" post="species that did not previously infect humans. Table 1."/>
   <result pre="infect humans. Table 1. Major developments in the technology of" exact="virus" post="discovery (adapted from [ 8]). year technology 1890s filtration"/>
   <result pre="significant ( p &amp;lt; 0.05) upswings in the rate of" exact="virus" post="discovery: in 1930 (95% confidence intervals (CIs) 1927–1933) and"/>
   <result pre="rate of discovery in Australasia. Figure 2. Patterns in human" exact="virus" post="diversity. ( a) A pie chart showing the continent"/>
   <result pre="( a) A pie chart showing the continent where human" exact="virus" post="species were first reported ( n = 215, with"/>
   <result pre="human viruses by family. Twenty three families are represented; six" exact="virus" post="species remain unassigned to a family. Numbers of species"/>
   <result pre="in figure 2 b. The family containing the most human" exact="virus" post="species is the Bunyaviridae with 40; six families contain"/>
   <result pre="the Bunyaviridae with 40; six families contain just one human" exact="virus" post="species. These numbers are too small for statistical analysis"/>
   <result pre="most notable trend is that only a single new pox" exact="virus" post="has been discovered since 1972 (compared with 10 up"/>
   <result pre="Following the approach described previously [ 5], we modelled human" exact="virus" post="discovery since 1954, assuming a total number of species"/>
   <result pre="number of species available to be discovered—the species pool—of N" exact="virus" post="species, each discovered in any given year with probability"/>
   <result pre="trend in the mean and variance for the number of" exact="virus" post="species discovered per year (based on 5 million simulations"/>
   <result pre="is considerable uncertainty as to the size of the human" exact="virus" post="species pool, this analysis suggests that there are at"/>
   <result pre="upper confidence interval. This gave a projected number of new" exact="virus" post="species of 36 (95% CIs 20–57), corresponding to an"/>
   <result pre="projection, of course, makes no allowance for any improvements in" exact="virus" post="detection technology nor changes in discovery effort. (e) Recently"/>
   <result pre="we identified at least 14 putative new species of human" exact="virus" post="first reported during the 5 years 2005 to 2009"/>
   <result pre="if it were exceeded, given the considerable recent interest in" exact="virus" post="discovery and the advent of high throughput sequencing as"/>
   <result pre="a detection tool. Table 2. Examples of putative new human" exact="virus" post="species reported from 2005 to 2009 [ 11– 24]."/>
   <result pre="virus species reported from 2005 to 2009 [ 11– 24]." exact="virus" post="name family human bocavirus Parvoviridae parvovirus 4 Parvoviridae KI"/>
   <result pre="human bocavirus Parvoviridae parvovirus 4 Parvoviridae KI polyomavirus Polyomaviridae Melaka" exact="virus" post="Reoviridae WU polyomavirus Polyomaviridae astrovirus MLB1 Astroviridae Bundibugyo ebolavirus"/>
   <result pre="Picornaviridae human cosavirus E1 Picornaviridae astrovirus VA1 Astroviridae human papilloma" exact="virus" post="116 Papillomaviridae klassevirus Picornaviridae Lujo virus Arenaviridae (f) New"/>
   <result pre="VA1 Astroviridae human papilloma virus 116 Papillomaviridae klassevirus Picornaviridae Lujo" exact="virus" post="Arenaviridae (f) New virus families The discovery curve for"/>
   <result pre="virus 116 Papillomaviridae klassevirus Picornaviridae Lujo virus Arenaviridae (f) New" exact="virus" post="families The discovery curve for virus families is shown"/>
   <result pre="virus Arenaviridae (f) New virus families The discovery curve for" exact="virus" post="families is shown in figure 1 b. Here, a"/>
   <result pre="of the first published report of human infection by a" exact="virus" post="species from that family. There is too little data"/>
   <result pre="However, several viruses (specifically Torque Teno (TT) virus, TT mini" exact="virus" post="and TT midi virus) newly reported since 1988 remain"/>
   <result pre="family. It should also be noted that there are three" exact="virus" post="families that, although they do not contain any known"/>
   <result pre="families that, although they do not contain any known human" exact="virus" post="species, do contain species that infect other mammals: Arteriviridae"/>
   <result pre="biological process (a) Non-human reservoirs More than two-thirds of human" exact="virus" post="species are zoonotic, i.e. they are capable of infecting"/>
   <result pre="species [ 30], including: HIV-1 (derived from a simian immunodeficiency" exact="virus" post="found in chimpanzees); HIV-2 (sooty mangabeys); severe acute respiratory"/>
   <result pre="found in chimpanzees); HIV-2 (sooty mangabeys); severe acute respiratory syndrome" exact="virus" post="(SARS; horseshoe bats); hepatitis B, human T-lymphotropic virus (HTLV)-1"/>
   <result pre="respiratory syndrome virus (SARS; horseshoe bats); hepatitis B, human T-lymphotropic" exact="virus" post="(HTLV)-1 and -2, dengue and yellow fever (all primates);"/>
   <result pre="is likely to reflect both the molecular biology of the" exact="virus" post="(e.g. is it capable of entering and replicating in"/>
   <result pre="the host–pathogen interaction, especially whether it is possible for the" exact="virus" post="to access tissues from which it can exit the"/>
   <result pre="This is a function of both the transmissibility of the" exact="virus" post="(how infectious an infected host is, and for how"/>
   <result pre="26, 34], it is possible to put approximate numbers of" exact="virus" post="species at each level of the pyramid. We know"/>
   <result pre="reported elsewhere (R. Critchlow 2010, personal communication) that of the" exact="virus" post="species known to infect domestic animals (livestock and companion"/>
   <result pre="multiple causes (good examples would be the emergence of Nipah" exact="virus" post="or SARS coronavirus). Other ideas about drivers of emergence"/>
   <result pre="range One likely biological determinant of the ability of a" exact="virus" post="to jump between species is whether or not they"/>
   <result pre="review of the peer reviewed literature and identified 88 human" exact="virus" post="species for which at least one cell receptor has"/>
   <result pre="families. On the basis of a previously published study of" exact="virus" post="host ranges [ 26], we accorded these viruses either"/>
   <result pre="result ( , p = 0.015). Figure 4. Number of" exact="virus" post="species with broad (blue bars) or narrow (red bars)"/>
   <result pre="receptor is a necessary but not sufficient condition for a" exact="virus" post="to have a broad host range encompassing different mammalian"/>
   <result pre="by the rate of human contact with a diversity of" exact="virus" post="genotypes (possibly rare genotypes) within the non-human reservoir (i.e."/>
   <result pre="eventually slow down or stop (if the bulk of new" exact="virus" post="species constitute extant diversity) or whether it will continue"/>
   <result pre="will continue indefinitely (if a significant proportion of newly discovered" exact="virus" post="species are newly evolved) remains unclear, although this makes"/>
   <result pre="There is a hint, from the slower accumulation of new" exact="virus" post="families found in humans, that virus diversity may be"/>
   <result pre="slower accumulation of new virus families found in humans, that" exact="virus" post="diversity may be bounded, but that does not preclude"/>
   <result pre="does not preclude there being a much larger number of" exact="virus" post="species ‘out there’ than we are currently aware of."/>
   <result pre="are in the midst of a period of particularly rapid" exact="virus" post="emergence and, in any case, with the advent of"/>
   <result pre="emergence and, in any case, with the advent of new" exact="virus" post="detection technologies, we are very likely to be entering"/>
   <result pre="are very likely to be entering a period of accelerated" exact="virus" post="discovery. The unavoidable conclusion is that we must anticipate"/>
   <result pre="17 Towner J. S. et al. 2008 Newly discovered Ebola" exact="virus" post="associated with hemorrhagic fever outbreak in Uganda. PLoS Pathog."/>
   <result pre="2010 Host phylogeny constrains cross-species emergence and establishment of rabies" exact="virus" post="in bats . Science 329, 676– 679 10.1126/science.1188836 ("/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="./PMC3544629/results/search/virus_topics/results.xml">
   <result pre="LRTIs and pediatric LRTI hospitalizations specifically due to respiratory syncytial" exact="virus" post="(RSV), respectively. The average length of stay was 3.1"/>
   <result pre="Lower respiratory tract infections (LRTIs) in children and infants are" exact="common" post="and can require hospitalization; thus, they are a major"/>
   <result pre="public health concern. A number of viruses including respiratory syncytial" exact="virus" post="(RSV), influenza viruses, parainfluenza viruses, rhinovirus, and adenovirus are"/>
   <result pre="for LRTIs. In children and infants, RSV is the most" exact="common" post="cause; during the first year of life 50%–70% of"/>
   <result pre="infections ICD-10 Code Description J10.1 Influenza due to other influenza" exact="virus" post="with J10.81 Influenza gastroenteritis J10.89 Influenza due to other"/>
   <result pre="with J10.81 Influenza gastroenteritis J10.89 Influenza due to other influenza" exact="virus" post="with J12.0 Adenoviral pneumonia J12.1 Respiratory syncytial virus pneumonia"/>
   <result pre="other influenza virus with J12.0 Adenoviral pneumonia J12.1 Respiratory syncytial" exact="virus" post="pneumonia J12.2 Parainfluenza virus pneumonia J12.3 Pneumonia due to"/>
   <result pre="J12.0 Adenoviral pneumonia J12.1 Respiratory syncytial virus pneumonia J12.2 Parainfluenza" exact="virus" post="pneumonia J12.3 Pneumonia due to SARS-associated coronavirus J12.8 Other"/>
   <result pre="bronchitis due to streptococcus J20.3 Acute bronchitis due to coxsackie" exact="virus" post="J20.4 Acute bronchitis due to parainfluenza virus J20.5 Acute"/>
   <result pre="due to coxsackie virus J20.4 Acute bronchitis due to parainfluenza" exact="virus" post="J20.5 Acute bronchitis due to respiratory syncytial virus J20.6"/>
   <result pre="to parainfluenza virus J20.5 Acute bronchitis due to respiratory syncytial" exact="virus" post="J20.6 Acute bronchitis due to rhinovirus J20.7 Acute bronchitis"/>
   <result pre="Pneumonia, unspecified organism J21.0 Acute bronchiolitis due to respiratory syncytial" exact="virus" post="J21.1 Acute bronchiolitis due to human metapneumovirus J21.8 Acute"/>
   <result pre="of LRTI hospitalizations among all children B. Pediatric respiratory syncytial" exact="virus" post="(RSV) specific hospitalizations. Infants &amp;lt;1 year of age accounted"/>
   <result pre="of age occurred between November and April. B. Respiratory syncytial" exact="virus" post="(RSV) specific hospitalizations in all children. 88.1% RSV hospitalizations"/>
   <result pre="Carbonell-Estrany X Impact of severe disease caused by respiratory syncytial" exact="virus" post="in children living in developed countries Pediatr Infect Dis"/>
   <result pre="NE Mitchell I Robinson JL Economic evaluation of respiratory syncytial" exact="virus" post="infection in Canadian children: a Pediatric Investigators Collaborative Network"/>
   <result pre="A Lanctot KL Langley JM A decade of respiratory syncytial" exact="virus" post="epidemiology and prophylaxis: Translating evidence into everyday clinical practice"/>
   <result pre="BJ Carbonell-Estrany X Simoes EA An update on respiratory syncytial" exact="virus" post="epidemiology: a developed country perspective Respir Med 2002 96"/>
   <result pre="AL Anderson LJ Variation in the timing of respiratory syncytial" exact="virus" post="outbreaks. Lessons from national surveillance Pediatr Infect Dis J"/>
   <result pre="Simoes EA Environmental and demographic risk factors for respiratory syncytial" exact="virus" post="lower respiratory tract disease J Pediatr 2003 143 S118"/>
   <result pre="costs in the US for preterm infants with respiratory syncytial" exact="virus" post="lower respiratory infection in the first year of life"/>
   <result pre="cohorting in prevention of hospital acquired infections with respiratory syncytial" exact="virus" post="Arch Dis Child 1991 66 227 231 10.1136/adc.66.2.227 2001109"/>
   <result pre="66 227 231 10.1136/adc.66.2.227 2001109 Austin J Preventing respiratory syncytial" exact="virus" post="in homebound premature infants Home Healthc Nurse 2007 25"/>
   <result pre="collab: The IMpact-RSV Study Group Palivizumab, a humanized respiratory syncytial" exact="virus" post="monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection"/>
   <result pre="respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial" exact="virus" post="infection in high-risk infants Pediatrics 1998 102 3 Pt1"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="./PMC3702433/results/search/virus_topics/results.xml">
   <result pre="respiratory tract infection (LRTI) including Community-acquired pneumonia (CAP) is a" exact="common" post="infectious disease that is associated with significant morbidity and"/>
   <result pre="eating for more than 7 days. Status of human immunodeficiency" exact="virus" post="(HIV) infection was not routinely tested but positive results"/>
   <result pre="previously described respiratory viruses: influenza A/B (FLUA, FLUB), respiratory syncytial" exact="virus" post="(RSV), Human adenovirus (HAdV), Human rhinovirus (HRV), Human bocavirus"/>
   <result pre="rhinovirus (HRV), Human bocavirus (HBoV), Human metapneumovirus (HMPV), Human parainfluenza" exact="virus" post="(HPIV) type 1–4, and Human coronavirus OC43/229E (HCoV) ["/>
   <result pre="the findings of the chest X-rays. As there are no" exact="common" post="criteria to interpret adult chest X-ray, the World Health"/>
   <result pre="in 151 (62%). In 26 (11%) of the cases, both" exact="virus" post="and bacterial pathogens were detected, but there was no"/>
   <result pre="but there was no significant association between the detection of" exact="virus" post="and of bacteria. HMPV, HBoV, PIV1-4, and HCoV were"/>
   <result pre="CAP H. influenzae and S. pneumoniae are known to be" exact="common" post="causes of adult CAP. Similarly, these pathogens were most"/>
   <result pre="of S. pneumoniae in nasopharyngeal swabs was significantly higher in" exact="virus" post="co-infected patients [ 17]. In the current study, patients"/>
   <result pre="longer duration prior to hospital admission compared with patients with" exact="virus" post="infection. It is plausible that patients with single bacterial"/>
   <result pre="for aging population. H. influenza, S. pneumoniae and Influenza A" exact="virus" post="were major pathogen detected. Competing interests The authors declare"/>
   <result pre="Hennessey PA Formica MA Cox C Walsh EE Respiratory syncytial" exact="virus" post="infection in elderly and high-risk adults N Eng J"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="./PMC3787546/results/search/virus_topics/results.xml">
   <result pre="(2011) showed that short-course systemic steroid treatment did not affect" exact="viral load" post="or shedding, and humoral immunity may be diminished by"/>
   <result pre="Hussell T. Openshaw P. Johnston S. L. ( 2012). The" exact="microbiology" post="of asthma. Nat. Rev. Microbiol. 10 459– 471 10.1038/nrmicro2801"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="./PMC4142007/results/search/virus_topics/results.xml">
   <result pre="was believed to be due to a mutation affecting the" exact="viral envelope" post="protein allowing replication in an alternate mosquito vector, A."/>
   <result pre="controls who were RNA positive or seroconverted having a median" exact="viral load" post="of 3·4 × 10 3 pfu/ml (range: 8·4 ×"/>
   <result pre="for 17 or fewer days. Symptomatic individuals had a median" exact="viral load" post="of 5·6 × 10 5 pfu/ml (range: 1·3 ×"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="./PMC4589665/results/search/virus_topics/results.xml">
   <result pre="sequenced sample, at varying concentrations and sequencing depth. If the" exact="viral load" post="in the sample is sufficient to produce overlapping sequencing"/>
   <result pre="et al., 2014) and to verify cross-assemblies of a novel" exact="bacteriophage" post="present in 73% of all publicly available gut metagenomes"/>
   <result pre="Boling L. et al. . ( 2014). A highly abundant" exact="bacteriophage" post="discovered in the unknown sequences of human faecal metagenomes"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="./PMC5309255/results/search/virus_topics/results.xml">
   <result pre="of clinicians, and limited surveillance efforts. Classical food- and waterborne" exact="viral disease" post="outbreaks are mainly caused by caliciviruses, but the source"/>
   <result pre="difficult to discriminate from human-to-human transmission. Atypical food- and waterborne" exact="viral disease" post="can be caused by viruses such as hepatitis A"/>
   <result pre="hepatitis A (HAV), and hepatitis E (HEV). High levels of" exact="viral shedding" post="through stool and vomit lead to dispersal in the"/>
   <result pre="there is limited coverage in surveillance of food- and waterborne" exact="viral disease," post="hampering detecting and tracing ( Ahmed et al., 2014;"/>
   <result pre="captures the tip of the iceberg of food- and waterborne" exact="viral disease" post="cases. FIGURE 1 Schematic representation of the phenomenon known"/>
   <result pre="means that outbreaks often are merely registered. Of the 941" exact="viral disease" post="outbreaks reported as foodborne in the joint ECDC-EFSA surveillance"/>
   <result pre="et al., 2014). To be able to recognize food- waterborne" exact="viral disease" post="outbreaks and stop underestimation of its disease burden there"/>
   <result pre="used with some success to quantify the contribution of foodborne" exact="viral disease" post="stemming from environmentally contaminated food (e.g., associated with shellfish;"/>
   <result pre="sequence data for reliable source-tracking. It does allow very rapid" exact="virus classification" post="in cases where low coverage suffices, or at high"/>
   <result pre="miss-annotated and the sequence was shown to belong to a" exact="bacteriophage" post="( Cantalupo et al., 2011). The volume of sequencing"/>
   <result pre="realistic insight in the global burden of food- and waterborne" exact="viral disease," post="and to make informed decisions on how to reduce"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="./PMC5325067/results/search/virus_topics/results.xml">
   <result pre="washed well? Proper cleansing with soap and water reduces the" exact="viral load" post="in local wounds. Injury Does the injury require sutures?"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="./PMC5327784/results/search/virus_topics/results.xml">
   <result pre="17]. Specific processes such as gene mutation, genetic recombination, or" exact="reassortment" post="as well as factors that compel microbial agents to"/>
   <result pre="In HIV disease treatment, for example, measurement of plasma HIV-1" exact="viral load" post="is an important technique for monitoring treatment efficacy ["/>
   <result pre="90 Calmy A. Ford N. Hirschel B. et al. HIV" exact="viral load" post="monitoring in resource-limited regions: optional or necessary? Clinical Infectious"/>
   <result pre="1890, 1918, 1957 Pandemic Influenza Paramyxovirus influenza A Animal-human virus" exact="reassortment" post="and antigenic shift 1969 Lassa fever Arenavirus Lassa virus"/>
   <result pre="1957 Pandemic Influenza Paramyxovirus influenza A Animal-human virus reassortment and" exact="antigenic shift" post="1969 Lassa fever Arenavirus Lassa virus Hospital exposure to"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="./PMC5435908/results/search/virus_topics/results.xml">
   <result pre="applied exogenously, and viral mRNA remains an important target for" exact="antiviral drug" post="discovery. To impair viral RNA transcription, different strategies have"/>
   <result pre="drugs targeting RNA have provided drug-like small molecules that inhibit" exact="viral replication" post="and include inhibitors of human immunodeficiency virus (HIV), hepatitis"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="./PMC5493079/results/search/virus_topics/results.xml">
   <result pre="Three serial readings of PCT were collected in addition to" exact="microbiology" post="culture results and whether the patient met the definition"/>
   <result pre="below this cut off had evidence of sepsis or positive" exact="microbiology" post="culture. The Area under the ROC was 0.702 with"/>
   <result pre="sensitivity pattern were all collected. Results: During this period, the" exact="microbiology" post="lab received a total of 1991 urine samples, 77"/>
   <result pre="Uruguay Introduction Critical illness is characterized by changes in the" exact="microbiology" post="of the intestinal tract, leading to a loss of"/>
   <result pre="consistent with infection and 19 patients (70.4 %) had positive" exact="microbiology" post="results within the first 7 days of ketamine administration."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="./PMC5605151/results/search/virus_topics/results.xml">
   <result pre="tissue culture infective dose assay. The effect of CPC on" exact="viral envelope" post="morphology and ultrastructure was evaluated using transmission electron microscopy"/>
   <result pre="using TEM showed that CPC disrupted the integrity of the" exact="viral envelope" post="and its morphology. Influenza viruses demonstrated no resistance to"/>
   <result pre="resistant strains of influenza virus by targeting and disrupting the" exact="viral envelope." post="Substantial virucidal activity is seen even at very low"/>
   <result pre="of CPC against influenza virus involves rapid disruption of the" exact="viral envelope" post="The mechanism of action of CPC against influenza virus"/>
   <result pre="( Figure 2A). Second, TEM analyses showed that while the" exact="viral envelope" post="of untreated influenza viruses was intact, exposure to CPC"/>
   <result pre="electron microscopy (TEM) demonstrating CPC disrupts the integrity of the" exact="viral envelope" post="and morphology of influenza virus. (A) Untreated influenza virus,"/>
   <result pre="CPC acts against influenza virus by rapid disruption of the" exact="viral envelope." post="Figure 4. Influenza nucleoprotein release from the virus in"/>
   <result pre="phosphatidylethanolamine dominates. In addition, analysis of lipid species of the" exact="viral envelope" post="revealed subtle differences between influenza A and B strains"/>
   <result pre="reported by Maillard et al who found that disruption of" exact="bacteriophage" post="F116 structure occurred within minutes following CPC exposure ["/>
   <result pre="TEM and nucleoprotein release studies showed that CPC disrupts the" exact="viral envelope." post="Although these experiments were performed using influenza B as"/>
   <result pre="CPC has been shown to cause structural damage in non-enveloped" exact="bacteriophage" post="[ 40], this agent may have activity against non-enveloped"/>
   <result pre="analogous to the activity against bacteria and fungi. Since the" exact="viral envelope" post="is host derived, the physicochemical mechanism of CPC is"/>
   <result pre="against influenza via direct virucidal activity by disruption of the" exact="viral envelope" post="and no indication of resistance selection. Increased survival was"/>
   <result pre="disease caused by novel influenza A H7N9 virus and sustained" exact="viral shedding" post="and emergence of antiviral resistance . Lancet. 2013; 381("/>
   <result pre="JL , Thomas PG , Brown HA Lipid composition of" exact="viral envelope" post="of three strains of influenza virus - not all"/>
   <result pre="investigation of the effects of biocides on Pseudomonas aeruginosa PAO" exact="bacteriophage" post="F116 . J Med Microbiol. 1995; 42( 6): 415–"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="./PMC5683535/results/search/virus_topics/results.xml">
   <result pre="the growth and spread of viruses such as human immunodeficiency" exact="virus" post="(HIV), Zika, and dengue and bacteria such as Methicillin-resistant"/>
   <result pre="imperative given our knowledge of the role of recombination in" exact="virus" post="adaptation [ 40], for example. More details on methods"/>
   <result pre="65]. Results and Discussion Evolutionary reconstruction of spatiotemporal transmission: dengue" exact="virus" post="and applications to other vector-borne tropical pathogens Combining pathogen"/>
   <result pre="was used recently to identify potential determinants of the dengue" exact="virus" post="(DENV) introduction to and spread within Brazil. Results from"/>
   <result pre="for effective control. The evolution of an epidemic revolution: Zika" exact="virus" post="With the development of molecular clock models for serially"/>
   <result pre="with these particular events. Since the inception of the Zika" exact="virus" post="(ZIKV) pandemic around May of 2015 in Brazil ["/>
   <result pre="to Senegal, and the second involved the spread of the" exact="virus" post="from Nigeria to West Africa. Results from spatiotemporal analysis"/>
   <result pre="the hub of the African epidemic as well as the" exact="common" post="ancestor of the Malaysian lineages sampled during the 1966"/>
   <result pre="the scientific community. Understanding both the rapid spread of the" exact="virus" post="throughout South and Central America and the Caribbean as"/>
   <result pre="the Caribbean as well as the initial emergence of the" exact="virus" post="from the Ugandan Zika forest in the early 1900s"/>
   <result pre="an important role, as with the emergence of human immunodeficiency" exact="virus" post="type 1 (HIV-1) group M subtypes A and D"/>
   <result pre="evolution of rapidly evolving viruses, greatly advancing the fields of" exact="virus" post="vaccine and treatment strategies [ 23]. On the other"/>
   <result pre="diseases. Abbreviations BEAST Bayesian Evolutionary Analysis Sampling Trees DENV Dengue" exact="virus" post="GIS Geographical information systems HIV Human immunodeficiency virus MRSA"/>
   <result pre="DENV Dengue virus GIS Geographical information systems HIV Human immunodeficiency" exact="virus" post="MRSA Methicillin-resistant Staphylococcus aureus NGS Next-generation sequencing NICU Neonatal"/>
   <result pre="care unit SNP Nucleotide polymorphism WGS Whole-genome sequencing ZIKV Zika" exact="virus" post="Electronic supplementary material The online version of this article"/>
   <result pre="NR, da Silva Azevedo dS, Kraemer MUG, et al. Zika" exact="virus" post="in the Americas: Early epidemiological and genetic findings. Science."/>
   <result pre="AC Salemi M et al. Towards a new paradigm linking" exact="virus" post="molecular evolution and pathogenesis: experimental design and phylodynamic inference"/>
   <result pre="al. Air travel is associated with intracontinental spread of dengue" exact="virus" post="serotypes 1-3 in Brazil PLoS Negl Trop Dis 2014"/>
   <result pre="et al. Zika: the origin and spread of a mosquito-borne" exact="virus" post="Bull World Health Organ 2016 94 675 86C 10.2471/BLT.16.171082"/>
   <result pre="M Mulanga-Kabeya C et al. Unprecedented degree of human immunodeficiency" exact="virus" post="type 1 (HIV-1) group M genetic diversity in the"/>
   <result pre="genetic signature of demographic and spatial expansion in epizootic rabies" exact="virus" post="Proc Natl Acad Sci 2007 104 7993 7998 10.1073/pnas.0700741104"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="./PMC5693564/results/search/virus_topics/results.xml">
   <result pre="J Kim EH Park SJ et al. Environmental contamination and" exact="viral shedding" post="in MERS patients during MERS-CoV outbreak in South Korea"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="./PMC5735522/results/search/virus_topics/results.xml">
   <result pre="Delobel P Izopet J Martin-Blondel G Zika virus: high infectious" exact="viral load" post="in semen, a new sexually transmitted pathogen? Lancet Infect"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="./PMC5765694/results/search/virus_topics/results.xml">
   <result pre="of infants hospitalized with RSV infection and associated with increased" exact="viral load" post="and enhanced mucosal CXCL8 responses http://orcid.org/0000-0003-0068-1275 Ederveen Thomas H."/>
   <result pre="We therefore studied the effect of the nasopharyngeal microbiome on" exact="viral load" post="and mucosal cytokine responses, two important factors influencing the"/>
   <result pre="between (i) the microbiome of the upper respiratory tract, (ii)" exact="viral load," post="and (iii) host mucosal inflammation during an RSV infection,"/>
   <result pre="controls were determined by 16S rRNA marker gene sequencing. The" exact="viral load" post="was measured using qPCR. Nasopharyngeal CCL5, CXCL10, MMP9, IL6,"/>
   <result pre="genus Haemophilus. We present that this bacterium is associated with" exact="viral load" post="and mucosal CXCL8 responses, both which are involved in"/>
   <result pre="of the smaller airways [ 6– 9]. In addition, high" exact="viral load" post="in the lungs and nasopharynx have been found in"/>
   <result pre="have been found in children with severe infection, suggesting that" exact="viral replication" post="also contributes to increased pathology [ 10– 12]. During"/>
   <result pre="severe, respectively). NPA samples were collected in which bacterial composition," exact="viral load," post="and host immune responses were measured to allow for"/>
   <result pre="(0) 3 (3) 8 (5) 14 (6) 0 (0) RSV" exact="viral load" post="(Ct) 50.0 (0) 22.4 (3.3) 27.0 (5.4) 23.6 (3.4)"/>
   <result pre="various parameters such as gender, age, (birth) weight, and RSV" exact="viral load" post="(Table 1 and Additional file 2: Figure S1). Infant"/>
   <result pre="with the interactive tree of life (iTOL) program RSV disease," exact="viral load," post="and CXCL8 levels can be explained by nasopharyngeal microbial"/>
   <result pre="by three RSV samples with &amp;lt; 0.01% relative abundance each. Both" exact="viral load" post="and host immune responses are hypothesized to play a"/>
   <result pre="and MMP9) [ 15, 27, 28]. Fig. 3 RSV disease," exact="viral load," post="and CXCL8 levels in healthy and RSV-infected individuals can"/>
   <result pre="that nasopharyngeal genus-level microbiota can significantly be separated based on" exact="viral load" post="( b) (Ct threshold plotted: higher Ct number corresponds"/>
   <result pre="number of PCR cycles before confident virus detection, hence lower" exact="viral load;" post="p value = 0.036). For a and b, the blue arrows"/>
   <result pre="similar analysis on the OTU level We found that RSV" exact="viral load" post="(as determined with qPCR, Ct) in nasopharyngeal aspirates of"/>
   <result pre="based on genus-level microbiota is not primarily driven by the" exact="viral load" post="contrast. Furthermore, RDA of healthy and RSV-infected individuals showed"/>
   <result pre="not shown). Interestingly, OTU-level analysis of microbiota associated with RSV" exact="viral load" post="provided increased insight with regard to Haemophilus-classified OTUs, as"/>
   <result pre="regard to Haemophilus-classified OTUs, as these best explained association with" exact="viral load" post="but not other OTUs in the top 10 response"/>
   <result pre="correlate to the outcome for clinical manifestation of RSV disease," exact="viral load," post="and CXCL8 immune response. RSV disease is marked with"/>
   <result pre="RSV disease severity is a multifactorial problem, in which the" exact="viral load" post="and the inflammatory response are important drivers of disease,"/>
   <result pre="to answer is whether nasopharyngeal microbiome composition relates to local" exact="viral load" post="and exerts an influence on mucosal immune responses. Viral"/>
   <result pre="composition. Haemophilus-dominated profiles were in part associated with an increased" exact="viral load" post="and increased IL6 and CXCL-8 responses on the genus"/>
   <result pre="and influence both the local immune response as well as" exact="viral load." post="Interactions between RSV, local mucosal nasopharyngeal microbial content, and"/>
   <result pre="confounding characteristics of this study. Figure S2 RSV disease and" exact="viral load" post="in healthy and RSV-infected individuals can be explained by"/>
   <result pre="1002 21881113 11. Houben ML et al. Disease severity and" exact="viral load" post="are correlated in infants with primary respiratory syncytial virus"/>
   <result pre="704 715 25865368 39. Franz A et al. Correlation of" exact="viral load" post="of respiratory pathogens and co-infections with disease severity in"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="./PMC5819479/results/search/virus_topics/results.xml">
   <result pre="we provide a catalogue of all 214 known human-infective RNA" exact="virus" post="species. We link these viruses to metadata for a"/>
   <result pre="very prominent among the emerging infectious diseases: SARS coronavirus, Ebola" exact="virus" post="and MERS coronavirus are recent, high profile examples 2"/>
   <result pre="of human-infective RNA viruses using two techniques, extrapolation of the" exact="virus" post="discovery curve 4 and an ecological diversity measure 6"/>
   <result pre="epidemic potential in human populations 2 . Chikungunya virus, Ebola" exact="virus" post="and Zika virus all met the criteria prior to"/>
   <result pre="human populations 2 . Chikungunya virus, Ebola virus and Zika" exact="virus" post="all met the criteria prior to their actual emergence"/>
   <result pre="8 ), and link this to metadata on seven different" exact="virus" post="traits. We describe the distribution of virus species by"/>
   <result pre="on seven different virus traits. We describe the distribution of" exact="virus" post="species by discovery date, transmissibility in human populations, non-human"/>
   <result pre="transmission route below. The database lists 214 ICTV-recognised, human-infective RNA" exact="virus" post="species (Data Citation 1). This is a substantial increase"/>
   <result pre="to a family). The accumulation of (currently) ICTV-recognised, human-infective RNA" exact="virus" post="species up to 2015 is depicted in Fig. 1."/>
   <result pre="back to 1901, when the discovery of the first human" exact="virus" post="species– Yellow fever virus–was reported. The number of species"/>
   <result pre="rates of discovery and the total diversity of human-infective RNA" exact="virus" post="species 4 . We note that there is often"/>
   <result pre="is often a lag of several years between a novel" exact="virus" post="being reported to infect humans and that virus being"/>
   <result pre="a novel virus being reported to infect humans and that" exact="virus" post="being recognised as a new species, or not, by"/>
   <result pre="of July 2017 there were more than 20 putative RNA" exact="virus" post="species in that category. For this reason we extend"/>
   <result pre="Figure 1 also depicts the accumulation of (currently) ICTV-recognised RNA" exact="virus" post="genera and families known to contain human-infective species. Each"/>
   <result pre="virus genera and families known to contain human-infective species. Each" exact="virus" post="is classified according to its known level of transmissibility"/>
   <result pre="Level 4b viruses are known only to infect humans. Where" exact="virus" post="species include subtypes known to have different levels of"/>
   <result pre="(apart from primates); birds; reptiles; and fish. The distribution of" exact="virus" post="species by host category is shown in Table 2."/>
   <result pre="ectotherms; and just 37 (17%) infect birds. There are 26" exact="virus" post="species (12%) that are only known to infect humans."/>
   <result pre="bites/broken skin; iatrogenic; vector (biting arthropod); maternal. The distribution of" exact="virus" post="species by transmission route is shown in Table 3."/>
   <result pre="July 21st 2017. The main ICTV criteria for defining RNA" exact="virus" post="species are: relatedness based on sequence data; serological cross-reactivity;"/>
   <result pre="and H7N9 that only occasionally infect humans. Although Influenza A" exact="virus" post="is exceptionally variable in this respect, there are other"/>
   <result pre="virus is exceptionally variable in this respect, there are other" exact="virus" post="species with distinct subtypes that differ in traits such"/>
   <result pre="all identified subtypes to make up the traits of that" exact="virus" post="species as a whole. Our list of human-infective RNA"/>
   <result pre=". We also followed up primary references linked to RNA" exact="virus" post="genome sequence data in NCBI [ www.ncbi.nlm.nih.gov/nucleotide/], where this"/>
   <result pre="Structured searches typically included the following key words: human and" exact="virus" post="and (case* or patient* or infection* or disease* or"/>
   <result pre="critical criteria for inclusion in the database are: i) RNA" exact="virus" post="species recognised by the International Committee for the Taxonomy"/>
   <result pre="of human infection. Only evidence of infections with the specific" exact="virus" post="species, or strains/variants falling under that species were accepted;"/>
   <result pre="was not considered a criterion for human infectivity. Where a" exact="virus" post="was only known to infect humans from serological methods,"/>
   <result pre="did not demonstrably occur. However, we have indicated where a" exact="virus" post="is known only from serological evidence; there are 36"/>
   <result pre="literature rather than direct testing of human infectivity for all" exact="virus" post="species listed. Discovery date Dates of first reported human"/>
   <result pre="following records for all 214 currently recognised species of RNA" exact="virus" post="for which there is published evidence of human infectivity."/>
   <result pre="ICTV website ( https://talk.ictvonline.org/). Column D: Whether or not the" exact="virus" post="is enveloped (1, 0). From the ICTV website ("/>
   <result pre="Discovery date as calendar year of first published report of" exact="virus" post="infecting humans. Obtained from literature review as described above."/>
   <result pre="available and hyperlink to reference). Column I: Whether or not" exact="virus" post="is known only from serological evidence (Y, N). Columns"/>
   <result pre="or unknown. Columns X to AC: Whether or not the" exact="virus" post="is known to be capable of infecting any of"/>
   <result pre="viruses known to infect humans. Table 1 Numbers of RNA" exact="virus" post="species that exhibit specified levels of transmissibility in human"/>
   <result pre="(human virus, not zoonotic) 26 Table 2 Numbers of RNA" exact="virus" post="species naturally infecting additional host categories. Note that many"/>
   <result pre="37 Reptiles 7 Fish 1 Table 3 Numbers of RNA" exact="virus" post="species with specified routes of transmission to humans. Note"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="./PMC6043914/results/search/virus_topics/results.xml">
   <result pre="restore the host immune response. HBV replication is dependent on" exact="capsid" post="assembly around pregenomic RNA (pgRNA) prior to synthesis of"/>
   <result pre="viruses. AB-423 also inhibits cccDNA synthesis, presumably by inhibiting the" exact="capsid" post="uncoating process. There is at least additive activity in"/>
   <result pre="172. The ISAR WIS Award Lecture: Small molecule inhibitors of" exact="viral entry" post="inspired by the humoral immune response to viral infection"/>
   <result pre="Using viral proteins (VPs) may open up new avenues for" exact="antiviral drug" post="discovery. This presentation will focus on a specific target"/>
   <result pre="stopping an infection developing to clinical symptoms. The antibodies prevent" exact="viral entry" post="into target cells, the earliest step in the viral"/>
   <result pre="viral entry into target cells, the earliest step in the" exact="viral life cycle." post="Could small molecules mimic this activity by binding to"/>
   <result pre="three days, to allow inhibitors of every step in the" exact="viral life cycle," post="including viral spread, to be identified. In secondary screens,"/>
   <result pre="open reading frame encoding all the VPs. There are four" exact="capsid" post="proteins (VP-1, 2, 3 and 4). Following the outbreak"/>
   <result pre="defined on the basis of threshold divergence in the VP1" exact="capsid" post="protein, There have been a few vaccine-associated paralytic polio"/>
   <result pre="sponsors to progress these compounds. Just two compounds, pocapavir (V-073," exact="capsid" post="inhibitor, preventing viral RNA release) and V-7404 (3C protease"/>
   <result pre="partner for up to eight years with longitudinal CD4 and" exact="viral load" post="(VL) following IAVI protocol C. For years, it has"/>
   <result pre="first (primary) resistance mutation will decrease the inhibition by the" exact="antiviral drug" post="but perhaps by a small degree. Then other mutations"/>
   <result pre="for clinical use, are effective tools to learn more about" exact="viral replication." post="Her compounds have given more information about the dengue"/>
   <result pre="and to the ongoing work investigating resistance to pocapavir (V-073," exact="capsid" post="inhibitor, preventing viral RNA release) and V-7404 (3C PI)."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="./PMC6156540/results/search/virus_topics/results.xml">
   <result pre="infectious diseases available. Adenoviridae are non-enveloped viruses with an icosahedral" exact="capsid" post="and a linear double-stranded DNA genome, whose size ranges"/>
   <result pre="293 cells that provide E1 protein in trans to allow" exact="viral replication." post="These production systems support high viral yields at relatively"/>
   <result pre="pre-existing immunity and the lack of a DNA intermediate during" exact="viral replication" post="makes VSV attractive as a safe vaccine for applications"/>
   <result pre="the viral matrix (M) protein, rearranging the order of the" exact="viral protein," post="insertion of non-viral proteins and partial or complete deletion"/>
   <result pre="(VRPs) produced by a helper cell line that provides the" exact="capsid" post="and glycoprotein genes in trans ( 134). While the"/>
   <result pre="cationic nanoemulsions (CNE) were immunogenic in ferrets, facilitating containment of" exact="viral replication" post="in the upper respiratory tract upon influenza infection and"/>
   <result pre="concerns due to the risk of adverse events and residual" exact="viral replication" post="upon delivery, as detected in a small number of"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="./PMC6369834/results/search/virus_topics/results.xml">
   <result pre="build the foundation of EU-oriented national reforms. Well-functioning public health" exact="microbiology" post="laboratories are key for early detection and control of"/>
   <result pre="and identified key areas for advancement toward effective public health" exact="microbiology" post="systems. Countries identified gaps in their laboratory data reporting"/>
   <result pre="article highlights the key areas for investing in public health" exact="microbiology" post="laboratories in Western Balkan countries needed to strengthen health"/>
   <result pre="strengthen health security in Europe. Western Balkan countries public health" exact="microbiology" post="external quality assessment molecular diagnostics antimicrobial susceptibility testing communicable"/>
   <result pre="disease prevention and control capacities. Strong capacity of public health" exact="microbiology" post="laboratory systems is crucial in providing timely and reliable"/>
   <result pre="candidate and potential candidate countries to improve the capacities of" exact="microbiology" post="laboratory systems to fulfill requirements set out by EU"/>
   <result pre="on cross-border health threats. Analysis of the current situation of" exact="microbiology" post="laboratories supporting public health in the countries suggests that"/>
   <result pre="suggests that despite a number of positive achievements in national" exact="microbiology" post="laboratory service capabilities, there is an urgent need for"/>
   <result pre="need for these countries to further improve their public health" exact="microbiology" post="systems before they join the EU. ECDC's Support to"/>
   <result pre="these countries into ECDC activities, including support to public health" exact="microbiology" post="systems. Upon request from the European Commission, ECDC has"/>
   <result pre="the six assessed areas was national systems of public health" exact="microbiology" post="laboratories. In 2013, an Observer role was established to"/>
   <result pre="institutes, to increase awareness about the importance of public health" exact="microbiology" post="in national communicable disease surveillance and control, thereby contributing"/>
   <result pre="majority of countries reported that being part of the ECDC" exact="microbiology" post="expert network helped them to prepare for implementation of"/>
   <result pre="a common need to define and further strengthen public health" exact="microbiology" post="laboratory systems to attain an adequate level of capability"/>
   <result pre="EQA was not offered. A regional ECDC multi-country workshop on" exact="microbiology" post="laboratory systems supporting public health in EU enlargement countries"/>
   <result pre="the region. In preparation for the ECDC Multi-country workshop on" exact="microbiology" post="laboratory systems supporting public health, in June 2017, in"/>
   <result pre="to be addressed. First, national regulations and nominations of reference" exact="microbiology" post="laboratories are often missing or ambiguous; re-assessment of the"/>
   <result pre="is no complete inventory nor a clear overview of all" exact="microbiology" post="laboratories; only half of the countries have a national"/>
   <result pre="of the countries have a national database of all available" exact="microbiology" post="laboratories operating in the public and private sectors. Four"/>
   <result pre="countries has established an electronic laboratory data reporting system from" exact="microbiology" post="laboratories to the public health central level. All countries"/>
   <result pre="doctors do not systematically test and/or refer patients for diagnostic" exact="microbiology" post="testing. In some countries, standard algorithms for performing laboratory"/>
   <result pre="laboratory personnel in clinical laboratories also hamper effective use of" exact="microbiology" post="diagnostic tests by physicians at primary level. Moreover, in"/>
   <result pre="levels. Even if many national reference laboratories and some clinical" exact="microbiology" post="laboratories participate in external quality assessments (EQA), in general"/>
   <result pre="the countries has external quality assessment systems covering all the" exact="microbiology" post="laboratories in the country. Perceived Needs of Countries to"/>
   <result pre="setting-up of effective electronic data reporting and exchange systems for" exact="microbiology" post="information. All countries expressed the need to develop new"/>
   <result pre="All countries expressed the need to develop new and innovative" exact="microbiology" post="methods and techniques, including next generation sequencing (NGS)/whole genome"/>
   <result pre="was seen as an important step to increase capabilities for" exact="microbiology" post="laboratory services for effective public health. The Western Balkan"/>
   <result pre="laboratory materials and reagents. This is likely to jeopardize effective" exact="microbiology" post="laboratory capacities to support clinical and public health response"/>
   <result pre="Membership This overview of the 2016 capacities of public health" exact="microbiology" post="laboratory systems in six Western Balkan countries identifies several"/>
   <result pre="regional gaps. To address the sustainability of financial resources for" exact="microbiology" post="laboratory services supporting public health there is an opportunity"/>
   <result pre="technical infrastructure and well trained personnel. To increase capabilities for" exact="microbiology" post="laboratory services and to develop them further, EU pre-accession"/>
   <result pre="countries. They should also consider application of new and emerging" exact="microbiology" post="laboratory methods and techniques. To remedy the problems related"/>
   <result pre="of specimens, and intergovernmental collaboration. To implement the policies/strategies on" exact="microbiology" post="laboratory systems including the necessary technical advancements it is"/>
   <result pre="help countries to promote necessary changes in national public health" exact="microbiology" post="systems and initiate their implementation, as well as to"/>
   <result pre="need for Western Balkan countries to improve their public health" exact="microbiology" post="systems before they join the EU to guarantee optimal"/>
   <result pre="than just enhancing technical capacities of epidemiology and public health" exact="microbiology" post="systems. It is also about engagement, cooperation and partnerships"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="./PMC6509602/results/search/virus_topics/results.xml">
   <result pre="of symptoms in some infectious individuals (‘silent man’) or prolonged" exact="viral shedding" post="post recovery. Priorities for future research/policy Improving basic EID"/>
   <result pre="species identification and drug susceptibility testing). Use of highly selective" exact="bacteriophage" post="therapy. Adaptive clinical trial designs for rapid assessment of"/>
   <result pre="without appropriate infection control measures. Alternative therapeutic strategies, such as" exact="bacteriophage" post="treatment may be successful if linked to rapid and"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="./PMC6593267/results/search/virus_topics/results.xml">
   <result pre="least one respiratory virus in ~30% of cases, although the" exact="viral load" post="was generally lower in carriers than in symptomatic subjects"/>
   <result pre="1994; Block et al., 1997; Falck et al., 1997). Long-term" exact="viral shedding" post="after a previous infection can further render the results"/>
   <result pre="screening program proved useful for identifying asymptomatically infected patients with" exact="viral shedding," post="thus reducing the risk of transmission and potential nosocomial"/>
   <result pre="improve the judgement of clinicians. However, the diagnosis of a" exact="viral disease" post="by a laboratory test can be interpreted as a"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="./PMC6594388/results/search/virus_topics/results.xml">
   <result pre="long time now; however, their ability to rapidly evolve through" exact="antigenic drift" post="and antigenic shift causes the emergence of new strains."/>
   <result pre="however, their ability to rapidly evolve through antigenic drift and" exact="antigenic shift" post="causes the emergence of new strains. A recent example"/>
   <result pre="polymerase inhibitors. Amantadine and rimantadine are adamantane derivatives that inhibit" exact="viral replication" post="by blocking the proton conductivity of the M2 ion"/>
   <result pre="well tolerated and was associated with a significant reduction in" exact="viral load" post="compared to the oseltamivir group. Time of alleviation of"/>
   <result pre="were observed in any of the virologic outcomes evaluated including" exact="viral shedding" post="or peak of virus load. Virus Polymerase Inhibitors Pimodivir"/>
   <result pre="phase 2b clinical study (NCT02342249) treatment with pimodivir significantly decreased" exact="viral load" post="over 7 days versus placebo, in adult patients with"/>
   <result pre="by removing sialic receptors from the airway epithelium, therefore preventing" exact="viral entry" post="into cells of the respiratory epithelium ( Triana-Baltzer et"/>
   <result pre="(NCT01037205), it was observed that treatment with fludase significantly reduces" exact="viral load" post="and viral shedding after multiple doses. In addition, no"/>
   <result pre="observed that treatment with fludase significantly reduces viral load and" exact="viral shedding" post="after multiple doses. In addition, no significant adverse effects"/>
   <result pre="it was associated with a reduction of symptoms and infectious" exact="viral load" post="( Haffizulla et al., 2014). A phase 3 study"/>
   <result pre="cotton rats demonstrated that REGN2222 is effective at reducing RSV" exact="viral replication" post="in the lungs ( Gurnett-Bander et al., 2016). Although"/>
   <result pre="studies demonstrated that inhaled ALX-0171 inhibited RSV replication and reduced" exact="viral load" post="compared to placebo. ALX-0171 is currently in clinical trials"/>
   <result pre="indicated that oral administration of GS-5806 resulted in reduction of" exact="viral load" post="and disease severity ( Mackman et al., 2015). More"/>
   <result pre="hospitalized adults with RSV did not show significant reduction in" exact="viral load" post="or improvement of clinical outcomes to the disease ("/>
   <result pre="well as safety. It was shown that JNJ-53718678 reduced RSV" exact="viral load," post="respiratory infections’ severity caused by RSV, and duration of"/>
   <result pre="novel compound being developed to inhibit RSV replication by blocking" exact="viral entry" post="into the target cells. A placebo-controlled phase 1 clinical"/>
   <result pre="group compared with placebo recipients, and the reduction in RSV" exact="viral load" post="ranged from 73 to 88% in nasal washes of"/>
   <result pre="the RNA-dependent RNA polymerase 3 NCT02026349 NCT02008344 Fludase Influenza Prevents" exact="viral entry" post="into cells of the respiratory epithelium 2 NCT01037205 Nitazoxanide"/>
   <result pre="2017). Drug candidates and model systems in respiratory syncytial virus" exact="antiviral drug" post="discovery. Biochem. Pharmacol. 127, 1– 12. 10.1016/j.bcp.2016.09.014 , PMID:"/>
   <result pre="M. Villanueva J. et al. . ( 2014). An investigational" exact="antiviral drug," post="DAS181, effectively inhibits replication of zoonotic influenza A virus"/>
   <result pre="influenza A and B virus, leads to rapid and profund" exact="viral load" post="reduction &quot; in Options for the control of influenza"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="./PMC6727070/results/search/virus_topics/results.xml">
   <result pre="aetiological distribution of pneumonia. 7, 8, 9 This approach integrates" exact="microbiology" post="results from multiple specimens types and multiple results for"/>
   <result pre="excluded an additional two cases and 27 controls missing all" exact="microbiology" post="test results. The secondary all-case aetiology analysis (ie, regardless"/>
   <result pre="included 3968 cases and 5075 controls with at least one" exact="microbiology" post="test result ( figure 1); of the 3972 cases"/>
   <result pre="144 (3·0%) of 4779 controls (1·6, 1·2–2·1; appendix). Integrating the" exact="microbiology" post="results from the multiple specimens among the 1767 cases"/>
   <result pre="22403229 23 Feikin DR Fu W Park DE Is Higher" exact="viral load" post="in the upper respiratory tract associated with severe pneumonia?"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="./PMC6911100/results/search/virus_topics/results.xml">
   <result pre="used to evaluate where potential duplicates could lie, such as" exact="common" post="date fields (month_start, month_end, year_start, year_end) or consistent geographic"/>
   <result pre="middle East respiratory syndrome coronavirus by characterization of a conspecific" exact="virus" post="from an African bat. J Virol. 2014; 88(19): 11297-303."/>
   <result pre="Kayali G. Seroepidemiology for MERS coronavirus using microneutralisation and pseudoparticle" exact="virus" post="neutralisation assays reveal a high prevalence of antibody in"/>
   <result pre="serological evidence of Middle East respiratory syndrome coronavirus infection in" exact="virus" post="exposed camel abattoir workers in Nigeria, 2016. Euro Surveill."/>
   <result pre="and response strategies to combat the potential spread of MERS-CoV" exact="virus" post="through migrant workers in Sri Lanka. F1000Res. 2013; 2:"/>
   <result pre="Hemmati P, Dadras M, Gouya MM, Mokhtari Azad T. Influenza" exact="virus" post="but not MERS coronavirus circulation in Iran, 2013–2016: Comparison"/>
   <result pre="Messina JP et al. A global compendium of human dengue" exact="virus" post="occurrence Sci. Data 2014 1 140004 10.1038/sdata.2014.4 25977762 21."/>
   <result pre="et al. A global compendium of human Crimean-Congo haemorrhagic fever" exact="virus" post="occurrence Sci. Data 2015 2 150016 10.1038/sdata.2015.16 25977820 22."/>
   <result pre="et al. Updates to the zoonotic niche map of Ebola" exact="virus" post="disease in Africa eLife 2016 5 e16412 10.7554/eLife.16412 27414263"/>
   <result pre="et al. Seroepidemiology for MERS coronavirus using microneutralisation and pseudoparticle" exact="virus" post="neutralisation assays reveal a high prevalence of antibody in"/>
   <result pre="Peyman Dadras Mohhamadnasr Gouya Mohammad Mehdi Mokhtari Azad Talat Influenza" exact="virus" post="but not MERS coronavirus circulation in Iran, 2013–2016: Comparison"/>
   <result pre="and response strategies to combat the potential spread of MERS-CoV" exact="virus" post="through migrant workers in Sri Lanka. F1000Research 2 (2013)."/>
   <result pre="serological evidence of Middle East respiratory syndrome coronavirus infection in" exact="virus" post="exposed camel abattoir workers in Nigeria, 2016. Euro Surveill."/>
   <result pre="hemorrhage in a patient with Middle East respiratory syndrome corona" exact="virus" post="Saudi Med. J. 2017 38 196 200 10.15537/smj.2017.2.16255 28133694"/>
   <result pre="middle East respiratory syndrome coronavirus by characterization of a conspecific" exact="virus" post="from an African bat J. Virol. 2014 88 11297"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="./PMC6925075/results/search/virus_topics/results.xml">
   <result pre="2009, Middle East respiratory syndrome coronavirus (MERS-CoV) since 2012, Ebola" exact="virus" post="in 2013–2016 and from 2018 onward, and Zika virus"/>
   <result pre="Ebola virus in 2013–2016 and from 2018 onward, and Zika" exact="virus" post="in 2015–16 are some examples [ 5– 9]. In"/>
   <result pre="Janssen Vaccines and University of Oxford Lassa US$19.0 million Recombinant" exact="virus" post="Preclinical MERS-CoV Phase I Nipah Preclinical Profectus BioSciences, Emergent"/>
   <result pre="Profectus BioSciences, Emergent BioSolutions, and PATH Lassa US$36.0 million Recombinant" exact="virus" post="Preclinical Nipah US$25.0 million Protein subunit Preclinical International AIDS"/>
   <result pre="Preclinical International AIDS Vaccine Initiative (IAVI) Lassa US$54.9 million Recombinant" exact="virus" post="Preclinical IDT Biologika MERS-CoV US$36.0 million Recombinant virus Phase"/>
   <result pre="million Recombinant virus Preclinical IDT Biologika MERS-CoV US$36.0 million Recombinant" exact="virus" post="Phase I Themis Bioscience Lassa US$58.5 million Recombinant virus"/>
   <result pre="Recombinant virus Phase I Themis Bioscience Lassa US$58.5 million Recombinant" exact="virus" post="Phase I MERS-CoV Preclinical Chikungunya Phase III University of"/>
   <result pre="Chikungunya Phase III University of Tokyo Nipah US$31.0 million Recombinant" exact="virus" post="Phase I Inovio Pharmaceuticals Lassa US$56.0 million DNA Preclinical"/>
   <result pre="Phase II Colorado State University Rift Valley fever US$9.5million Attenuated" exact="virus" post="Preclinical Wageningen Bioveterinary Research Rift Valley fever US$12.5 million"/>
   <result pre="Preclinical Wageningen Bioveterinary Research Rift Valley fever US$12.5 million Attenuated" exact="virus" post="Phase I Valneva Chikungunya US$23.4 million Attenuated virus Phase"/>
   <result pre="million Attenuated virus Phase I Valneva Chikungunya US$23.4 million Attenuated" exact="virus" post="Phase I Public health vaccines Nipah US$43.6 million Recombinant"/>
   <result pre="virus Phase I Public health vaccines Nipah US$43.6 million Recombinant" exact="virus" post="Preclinical Imperial College London Marburg US$8.4 million RNA Preclinical"/>
   <result pre="Queensland MERS-CoV US$10.6 million Recombinant protein Preclinical Influenza Respiratory syncytial" exact="virus" post="The CEPI vaccine portfolio contains a wide variety of"/>
   <result pre="phase I/II and, potentially, phase III efficacy trials, access to" exact="common" post="sets of reference standards will be crucial for the"/>
   <result pre="GL Byahatti SM An insight into the swine-influenza A (H1N1)" exact="virus" post="infection in humans Lung India 2011 28 34 38"/>
   <result pre="9. Pereira AM Monteiro DLM Werner H et al. Zika" exact="virus" post="and pregnancy in Brazil: what happened? J Turk Ger"/>
   <result pre="2019 31. collab: WHO WHO target product profile for Lassa" exact="virus" post="vaccine 2017 32. collab: WHO WHO target product profiles"/>
   <result pre="2017 33. collab: WHO WHO target product profile for Nipah" exact="virus" post="vaccine 2017 34. Brighton Collaboration (2019) https://www.brightoncollaboration.org/. Accessed 28"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="./PMC6926486/results/search/virus_topics/results.xml">
   <result pre="from Saudi Arabia were chosen on the basis of initial" exact="viral load" post="quantification ( appendix p 1) for full genome analysis"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="./PMC6926871/results/search/virus_topics/results.xml">
   <result pre="the Poliovirus situation worldwide, in 2014 and 2019 the Ebola" exact="virus" post="disease (EVD) outbreak in West Africa and the Democratic"/>
   <result pre="Republic of the Congo respectively, and in 2016 the Zika" exact="virus" post="disease [ 5]. Moreover, in 2003 the Severe Acute"/>
   <result pre="[ 35], Influenza Pandemic (H1N1) 2009 [ 33] and Zika" exact="virus" post="disease [ 7] as an ad hoc measure at"/>
   <result pre="in DRC, Middle East respiratory syndrome (MERS), Yellow fever, Zika" exact="virus" post="disease, Plague and the Influenza Pandemic (H1N1) 2009 ["/>
   <result pre="routine basis. In particular, entry screening was applied for Zika" exact="virus" post="disease for a total of 10 months (January to"/>
   <result pre="responsible for decision-making regarding the Influenza Pandemic (H1N1) 2009, Zika" exact="virus" post="disease and Dengue fever screening measures [ 7, 15,"/>
   <result pre="39, 40]. One article referring to entry screening for Zika" exact="virus" post="disease [ 7] describes that travelers underwent visual assessment,"/>
   <result pre="38]. In an article describing entry screening procedures for Zika" exact="virus" post="disease in Taiwan, five out of 21,083,404 inbound screened"/>
   <result pre="of 21,083,404 inbound screened passengers were laboratory-confirmed cases of Zika" exact="virus" post="disease; whereas 130 cases of Dengue fever and four"/>
   <result pre="Africa in 2014/2015, SARS, Influenza Pandemic (H1N1) 2009 and Zika" exact="virus" post="disease, as well as entry screening measures implemented on"/>
   <result pre="[ 6, 27, 28, 31, 34, 37, 38]. For Zika" exact="virus" post="disease, five cases were identified and more than 21,000,000"/>
   <result pre="OF THE CONGO 2018. Strategic response plan for the Ebola" exact="virus" post="disease outbreak. ECDC 2014. Technical report: Infection prevention and"/>
   <result pre="2014. Technical report: Infection prevention and control measures for Ebola" exact="virus" post="disease Entry and exit screening measures. ECDC 2015. Mission"/>
   <result pre="Guidance Package. WORLD HEALTH ORGANISATION 2014b. Technical note for Ebola" exact="virus" post="disease preparedness planning for entry screening at airports, ports,"/>
   <result pre="2015. Systems for rapidly detecting and treating persons with ebola" exact="virus" post="disease--United States. MMWR Morb Mortal Wkly Rep, 64, 222–225."/>
   <result pre="DISEASE, C. &amp;amp; PREVENTION 2014. Importation and containment of Ebola" exact="virus" post="disease - Senegal, August-September 2014. MMWR Morb Mortal Wkly"/>
   <result pre="2014. Statement on infection prevention and control measures for Ebola" exact="virus" post="disease (December 2014). Can Nurse, 110, 17-8. READ, J."/>
   <result pre="health challenges and legacies of Japan’s response to the Ebola" exact="virus" post="disease outbreak in West Africa 2014 to 2015. Eurosurveillance,"/>
   <result pre="J. F., CENTERS FOR DISEASE, C. &amp;amp; PREVENTION 2014. Ebola" exact="virus" post="disease outbreak—Nigeria, July–September 2014. MMWR Morb Mortal Wkly Rep,"/>
   <result pre="K. &amp;amp; DE COCK, K. M. 2015. Evolution of ebola" exact="virus" post="disease from exotic infection to global health priority, Liberia,"/>
   <result pre="2015. Assessment of the potential for international dissemination of Ebola" exact="virus" post="via commercial air travel during the 2014 west African"/>
   <result pre="TADA, Y. &amp;amp; OKABE, N. 2009. Epidemiology of influenza A(H1N1)v" exact="virus" post="infection in Japan, May-June 2009. Euro Surveill, 14. WORLD"/>
   <result pre="born: Taiwan Centers for Disease Control’s response to emerging Zika" exact="virus" post="infection. Journal of the Formosan Medical Association, 115, 223–225."/>
   <result pre="2015 Yellow fever 31 Aug 2016/16 May 2017 - Zika" exact="virus" post="8 Mar 2016/18 Nov 2016 Statement on the 1st"/>
   <result pre="health challenges and legacies of Japan’s response to the Ebola" exact="virus" post="disease outbreak in West Africa 2014 to 2015 Eurosurveillance"/>
   <result pre="born: Taiwan Centers for Disease Control’s response to emerging Zika" exact="virus" post="infection J. Formos. Med Assoc. 2016 115 223 225"/>
   <result pre="Cheng C.-H. Yu S.-K. Lin C.-C. Shu P.-Y. Imported chikungunya" exact="virus" post="strains, Taiwan, 2006-2009 Emerg. Infect. Dis. 2009 15 1854"/>
   <result pre="A.J. Kamara O. et al. Asymptomatic infection and unrecognised Ebola" exact="virus" post="disease in Ebola-affected households in Sierra Leone: A cross-sectional"/>
   <result pre="study using a new non-invasive assay for antibodies to Ebola" exact="virus" post="Lancet Infect. Dis. 2017 17 645 653 10.1016/S1473-3099(17)30111-1 28256310"/>
   <result pre="al. Assessment of the potential for international dissemination of Ebola" exact="virus" post="via commercial air travel during the 2014 west African"/>
   <result pre="Published entry and exit screening measures in response to Ebola" exact="virus" post="disease outbreak [ 16, 27, 31, 34, 38, 41]."/>
   <result pre="7, 10, 11, 15] X - X - - Zika" exact="virus" post="disease Taiwan [ 7] X - X - -"/>
   <result pre="Taiwan [ 7] X - X - - Other Ebola" exact="virus" post="disease Australia [ 31], Japan [ 38], United States"/>
   <result pre="or trade restrictions (4/8/2018, ongoing, latest report on 5/12/2018) Ebola" exact="virus" post="disease outbreak in West Africa 8 August 2014/29 March"/>
   <result pre="March 2016 Yes (8/8/2014) 2014–2016 IHR Emergency Committee for Ebola" exact="virus" post="disease Exit screening in affected countries *, at international"/>
   <result pre="Νo international travel or trade restrictions (31/8/2016 to 16/5/2017) Zika" exact="virus" post="disease 1 February 2016/18 November 2016 Yes (1/2/2016) IHR"/>
   <result pre="2016/18 November 2016 Yes (1/2/2016) IHR Emergency Committee on Zika" exact="virus" post="disease and observed increase in neurological disorders and neonatal"/>
   <result pre="TMD Accompanying Measures at the Border Microbiological Tests Quarantine/Isolation Taiwan/airport/entry/Zika" exact="virus" post="disease /2016 [ 7] On board by crew or"/>
   <result pre="RT-PCR, and/or serological diagnosis by capture IgM/IgG ELISA) - Australia/airport/entry/Ebola" exact="virus" post="disease/2014-2015 [ 31] At airport by public health staff"/>
   <result pre="designated Viral Hemorrhagic Fever hospital and local tertiary hospital Belgium/airport/entry/Ebola" exact="virus" post="disease/2014 [ 27] - - Symptoms assessment (not specified)"/>
   <result pre="Altona commercial kit by Diagnostics GmbH, Hamburg, Germany - Japan/airport/entry/Ebola" exact="virus" post="disease/2014-2015 [ 38] At quarantine station, by immigration control"/>
   <result pre="assistance Laboratory test (not specified) Not specified / hospital UK/airport/entry/Ebola" exact="virus" post="disease/2014-2015 [ 27, 37] At airport, by infectious disease"/>
   <result pre="At local acute hospital or designated specialist hospital UK/train station/entry/Ebola" exact="virus" post="disease/2014-2015 [ 27, 37] At train station, by infectious"/>
   <result pre="specified/ At local acute hospital or designated specialist hospital US/airport/entry/Ebola" exact="virus" post="disease/2014-2015 [ 34] At airport facilities - Temperature screening"/>
   <result pre="and designated Ebola treatment centers Guinea, Liberia, and Sierra Leone/airport/exit/Ebola" exact="virus" post="disease/2014-2016 [ 6, 16] - Questionnaire at terminal Questionnaire"/>
   <result pre="boarding - - Guinea, Liberia, and Sierra Leone/land borders/exit /Ebola" exact="virus" post="disease/2014-2016 [ 16] - - Visual checks - -"/>
   <result pre="- - - - - Guinea, Liberia, and Sierra Leone/seaport/exit/Ebola" exact="virus" post="disease/2014-2016 [ 16] - - Temperature screening - -"/>
   <result pre="4 5.8% (95% CI 2.3–14.0%) † - [ 21] Ebola" exact="virus" post="disease US No information available &amp;gt;1200 travelers were referred"/>
   <result pre="2015 9 9 0 - - - [ 38] Zika" exact="virus" post="disease Taiwan January to October 2016 21,083,404 21,721 were"/>
   <result pre="3011 serum samples were sent for laboratory diagnosis of Dengue" exact="virus" post="infection. 40 - - 6005/73 [ 15] Chikungunya infection"/>
   <result pre="Confirmed Detected Confirmed Not Detected Guinea, Liberia, Sierra Leone Ebola" exact="virus" post="disease August to October 2014 80,000 0 No -"/>
   <result pre="9] Guinea, Liberia, Sierra Leone, Nigeria, Senegal, and Mali Ebola" exact="virus" post="disease &amp;gt;200,000 travelers leaving Guinea, Liberia, and Sierra Leone"/>
   <result pre="- - [ 28] Guinea, Liberia, and Sierra Leone Ebola" exact="virus" post="disease 12 August to 12 October 2014 36,000 77"/>
   <result pre="99.79% * [ 49] Guinea, Liberia, and Sierra Leone Ebola" exact="virus" post="disease August 2014 to January 2016 300,000 0 4"/>
   <result pre="to monitor this alarm system. &quot;The cost of identifying Dengue" exact="virus" post="infections with airport fever screening is similar to that"/>
   <result pre="20.3% (12 cases) of all imported cases.&quot; [ 33] Zika" exact="virus" post="disease/ Entry screening ad hoc/ Airport/ Taiwan Comparing confirmed"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="./PMC6935926/results/search/virus_topics/results.xml">
   <result pre="are 16 and 9 main variants, respectively ( 1). Genetic" exact="reassortment" post="underpins the potential for transmission between different host species"/>
   <result pre="and sample collection. We collected respiratory samples from the clinical" exact="microbiology" post="laboratory at Oxford University Hospitals NHS Foundation Trust, a"/>
   <result pre="for the majority of diagnostic samples processed by our clinical" exact="microbiology" post="laboratory. Further work is needed to investigate the sensitivity"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="./PMC6939334/results/search/virus_topics/results.xml">
   <result pre="to fuse foreign peptides with a coat protein (pIII) of" exact="bacteriophage" post="M13 in order to display peptides on the bacteriophage"/>
   <result pre="of bacteriophage M13 in order to display peptides on the" exact="bacteriophage" post="surface. He then created &quot;antibody-selectable phage vectors&quot; and described"/>
   <result pre="01/24/2000 03/16/2004 08/19/2016 US6753136 Methods for displaying (poly) peptides/proteins on" exact="bacteriophage" post="particles via disulfide bonds (HuCAL GOLD libraries) Morphosys AG"/>
   <result pre="G Mimicking somatic hypermutation: affinity maturation of antibodies displayed on" exact="bacteriophage" post="using a bacterial mutator strain J Mol Biol 1996"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="./PMC6941257/results/search/virus_topics/results.xml">
   <result pre="interaction between rabies virus and permissive host cell receptors -Reduced" exact="viral replication" post="in an in vitro infection model [ 84] VP35"/>
   <result pre="replication in an in vitro infection model [ 84] VP35" exact="viral protein" post="35, NP nucleoprotein, nsP10 NTPase/Helicase Moreover, aptamers may be"/>
   <result pre="gD protein of herpes simplex virus 1 and efficiently inhibits" exact="viral entry" post="J Virol 2012 86 12 6732 6744 10.1128/JVI.00377-12 22514343"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="./PMC6958603/results/search/virus_topics/results.xml">
   <result pre="Influenza Surveillance Evaluation Zambia Funding CDC,US NU511P000828-05-02). Background Seasonal influenza" exact="virus" post="infections are responsible for an estimated 291,243–645,832 respiratory deaths"/>
   <result pre="Zambia-ISSS were to: (i) monitor the temporal trends of influenza" exact="virus" post="circulation; (ii) monitor the circulating influenza virus types and"/>
   <result pre="trends of influenza virus circulation; (ii) monitor the circulating influenza" exact="virus" post="types and subtypes annually, including pandemic strains; (iii) assess"/>
   <result pre="meeting the ILI and SARI case definition attributable to influenza" exact="virus" post="infection; (iv) assess risk factors for influenza-associated severe illness;"/>
   <result pre="obtain and share clinical samples for annual selection of influenza" exact="virus" post="strains for influenza vaccine formulation under the WHO-Global Influenza"/>
   <result pre="with SARI were tested for other respiratory viruses including parainfluenza" exact="virus" post="(PIV) types 1, 2 and 3, respiratory syncytial virus"/>
   <result pre="parainfluenza virus (PIV) types 1, 2 and 3, respiratory syncytial" exact="virus" post="(RSV), adenovirus, rhinovirus, human metapneumovirus (hMPV), coronavirus (OC43, NL63,"/>
   <result pre="done using Haemagglutination (HA) and Haemagglutination Inhibition (HAI) testing. Confirmed" exact="virus" post="isolates were shared with WHO Collaborating Centers for further"/>
   <result pre="influenza epidemiological features/public health outcomes • Temporal patters of influenza" exact="virus" post="circulation (Yes) [ 3] Publications and reports 80.0% b"/>
   <result pre="[ 3] • Proportion of ILI/SARI illness attributable to influenza" exact="virus" post="infection (Yes) [ 3] • Risk factors for influenza-associated"/>
   <result pre="its objectives by (i) monitoring the temporal trends of influenza" exact="virus" post="circulation; (ii) monitoring the circulating influenza virus types and"/>
   <result pre="trends of influenza virus circulation; (ii) monitoring the circulating influenza" exact="virus" post="types and subtypes annually and enabling the detection of"/>
   <result pre="data from 15 African countries, the detection rate of influenza" exact="virus" post="among SARI and ILI cases was similar across the"/>
   <result pre="[ 3, 14] and other respiratory viruses [ 24] among" exact="common" post="respiratory syndromes in Zambia and globally through sharing of"/>
   <result pre="globally through sharing of influenza data [ 8, 28] and" exact="virus" post="isolates. Nonetheless, despite its moderate cost, the ISSS in"/>
   <result pre="K Oshitani H Saijo M et al. Epidemiology of influenza" exact="virus" post="infections in children with acute respiratory infections in Zambia"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="./PMC6961264/results/search/virus_topics/results.xml">
   <result pre="influenza [ 2- 4]. Due to frequent changes in circulating" exact="virus" post="strains, annual vaccination is recommended. However, the impact of"/>
   <result pre="deterministic and probabilistic methods to link the results of respiratory" exact="virus" post="tests performed by a network of 19 public health"/>
   <result pre="definitions Laboratory data We included the results of all respiratory" exact="virus" post="tests conducted by participating laboratories. The laboratories used monoplex"/>
   <result pre="metapneumovirus, influenza A, influenza B, parainfluenza virus, and respiratory syncytial" exact="virus" post="[ 19]. We combined the results of all specimens"/>
   <result pre="vaccine exposure in the current and previous seasons against a" exact="common" post="reference group of patients who were not vaccinated in"/>
   <result pre="Figure S5). Using the conventional approach of comparing to a" exact="common" post="reference group, VE did not differ substantially for patients"/>
   <result pre="does not consider the effects of multiple previous vaccine or" exact="virus" post="exposures [ 25]. Thompson et al. [ 26] examined"/>
   <result pre="cross-reactivity of immune responses elicited by previous vaccinations with current-season" exact="virus" post="antigens [ 17]. It is possible that due to"/>
   <result pre="MS has received research grants from Janssen Canada for respiratory" exact="virus" post="clinical trials. JBG has received research grants from GSK"/>
   <result pre="AJM, JDM, DCR, SER, AS, MS, and GZ provided respiratory" exact="virus" post="laboratory data. SAB, MAC, NSC, LCR, and KLS provided"/>
   <result pre="Hess KR Efficacy of repeated annual immunization with inactivated influenza" exact="virus" post="vaccines over a five year period. Vaccine. 1997; 15("/>
   <result pre="vaccine effectiveness in the 2011-2012 season: protection against each circulating" exact="virus" post="and the effect of prior vaccination on estimates. Clin"/>
   <result pre="Personnel on Serum Hemagglutinin Inhibition Antibody Response to A/Perth/16/2009 (H3N2)-like" exact="virus" post="during 2010-11. Vaccine. 2016; 34( 7): 981- 8. 10.1016/j.vaccine.2015.10.119"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="./PMC6969405/results/search/virus_topics/results.xml">
   <result pre="agents. Mostly, they are linked to bacteria, but often a" exact="viral disease" post="represents the basic infection. Viruses infecting reptiles and especially"/>
   <result pre="be classified. Afterwards two other snake samples with a higher" exact="viral load" post="were chosen for whole genome sequencing. A primer walking"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="./PMC6970282/results/search/virus_topics/results.xml">
   <result pre="stated. Abstract Background Tonsillitis, with associated tonsillar hypertrophy, is a" exact="common" post="disease of childhood, yet it is rarely associated with"/>
   <result pre="acute inflammation. Conclusion Palatine tonsillar hypertrophy in infants is a" exact="common" post="feature of both viral and bacterial tonsillitis and has"/>
   <result pre="infancy Autopsy Background Tonsillitis with associated tonsillar hypertrophy is a" exact="common" post="disease of childhood, yet it is rarely associated with"/>
   <result pre="glottis [ 5]. .Palatine tonsillar hypertrophy in infants is a" exact="common" post="feature of both viral and bacterial tonsillitis, and has"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="./PMC6979112/results/search/virus_topics/results.xml">
   <result pre="M. Berendt O20) Treatment of canine gliomas with systemic oncolytic" exact="virus" post="delivered by allogeneic mesenchymal stem cells I. Mateo, A."/>
   <result pre="Surgery, University of Milan‐Bicocca, Milano, Italy. Decompressive surgery is a" exact="common" post="treatment for intervertebral disc (IVD) herniation in dogs. Inadequate"/>
   <result pre="they are frequently reported in human epilepsy patients. In humans," exact="common" post="seizure‐precipitating factors include for example stress, sleep deprivation and"/>
   <result pre="deprivation and infectious diseases. We hypothesized that seizure‐precipitating factors are" exact="common" post="in dogs with idiopathic epilepsy, and the occurrence of"/>
   <result pre="one protective factor for seizures. In conclusion, seizure‐precipitating factors are" exact="common" post="in dogs with idiopathic epilepsy and the nature of"/>
   <result pre="Hebrew University of Jerusalem, Israel. Traumatic brain injury (TBI) is" exact="common" post="in dogs and can be life‐threatening. However, determining the"/>
   <result pre="Mean age was 2.75 years. Motor vehicle accident was the most" exact="common" post="inciting cause, followed by frontal collision (running into an"/>
   <result pre="Medical Science, University of Bologna. Tumor‐associated epilepsy (TAE) is a" exact="common" post="neurological sequela in glioma patients. The pathogenesis of TAE"/>
   <result pre="and 1 year after amputation. Signs related to PC are" exact="common" post="in amputated cats and the first week after amputation"/>
   <result pre="University of Parma, Italy. Brachial plexus avulsion (BPA) is a" exact="common" post="clinical circumstance in small animal practice. BPA can be"/>
   <result pre="dogs; 15/23 cats) (ethical committee approval is pending). The most" exact="common" post="neurological condition was inability to bear weight and absence"/>
   <result pre="and social life (25% dogs 14% cats). BPA represents a" exact="common" post="entity and its possible association to neuropathic pain must"/>
   <result pre="relationship exists between seizures and stress; stress is the most" exact="common" post="seizure precipitant in people with epilepsy, and recent research"/>
   <result pre="and Life Sciences, Poland. Epilepsy is one of the most" exact="common" post="neurological diseases in humans and dogs. In humans, there"/>
   <result pre="Valencia, Spain, 2Ars Veterinaria, Barcelona, Spain. Congenital vertebral malformations are" exact="common" post="findings in screw‐tailed brachycephalic breeds that can be treated"/>
   <result pre="of Forensic Medicine, Ministry of Justice, Taiwan. Melanoma is a" exact="common" post="neoplasia in dogs, accounting for 7% of all malignant"/>
   <result pre="in the adjacent intervertebral disks. In human medicine, the most" exact="common" post="cause is sclerotic metastatic bone disease (prostate, breast and"/>
   <result pre="School Hospital, Cambridge, United Kingdom. Intervertebral disc extrusion is a" exact="common" post="disease affecting chondrodystrophic dogs. It has previously been reported"/>
   <result pre="CVM was found, with lumbosacral transitional vertebrae being the most" exact="common" post="(34.2%). Pugs demonstrated significantly more often lumbosacral transitional vertebrae"/>
   <result pre="with evidence of hemivertebrae. As previously described, CVMs are a" exact="common" post="finding especially in the thoracic vertebral column of these"/>
   <result pre="All dogs showed at least one neurological abnormality, the most" exact="common" post="being abnormal mentation (79%), abnormal gait (61%) and cranial"/>
   <result pre="displacement and depression. Road traffic accident (RTA) was the most" exact="common" post="cause of trauma in both dogs and cats. In"/>
   <result pre="cats, mean age was 4.9 years, Domestic Shorthair was the most" exact="common" post="breed with 65% being males, and 46% having neurological"/>
   <result pre="United Kingdom, 2Newcastle University, United Kingdom. Epilepsy is the most" exact="common" post="chronic brain disease in dogs. Currently, seizures are considered"/>
   <result pre="(IVDD) (n=42), fracture/luxation (n=34), ischaemic myelopathy (n=22), feline infectious peritonitis" exact="virus" post="myelitis (n=18), lymphoma (n=16), vertebral canal stenosis (n=11), acute"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="./PMC6979267/results/search/virus_topics/results.xml">
   <result pre="tract infection 15.55‐16.10 ESVNU‐O‐7 Baumgartner Prognostic factors in dogs with" exact="common" post="causes of proteinuria 16.10‐16.25 ESVNU‐O‐8 Bijsmans The effect of"/>
   <result pre="21 September 16.30‐16.45 ESVIM‐O‐7 Jones Differences in clinical presentation of" exact="common" post="dog breeds diagnosed with primary IMHA 16.45‐17.00 ESVIM‐O‐8 de"/>
   <result pre="obstructive lower urinary tract disease ESVNU‐P‐6 Pagnamenta Non‐symptomatic bacteriuria is" exact="common" post="in young female boxer dogs ESVNU‐P‐7 Gori Evaluation of"/>
   <result pre="in the treatment of cats naturally infected with feline immunodeficiency" exact="virus" post="(FiV) ISCAID‐P‐8 Gatellet The many faces of Lyme borreliosis"/>
   <result pre="(CHF). Forty‐five cats had one or more comorbidities, the most" exact="common" post="were hyperthyroidism (16), diabetes mellitus (9), azotaemia (8). Fifteen"/>
   <result pre="of decompensation. Degenerative mitral valve disease (DMVD) is the most" exact="common" post="acquired canine cardiac disease. It is typically associated with"/>
   <result pre="Mantel‐Cox logrank comparison of Kaplan‐Meier survival curves. Overall, the most" exact="common" post="presentation was respiratory distress, (10 of 44 cats), followed"/>
   <result pre="dogs VPE was manifest and in 6 intermittent. The most" exact="common" post="d‐QRS complex morphology in lead II was the multiple"/>
   <result pre="variety of inhaled respiratory pathogens. Sinonasal aspergillosis (SNA) is a" exact="common" post="cause of chronic nasal disease that remains a challenge"/>
   <result pre="No disclosures to report. ESVIM‐O‐7 Differences in clinical presentation of" exact="common" post="dog breeds diagnosed with primary IMHA B. Jones 1,"/>
   <result pre="United Kingdom Canine primary immune‐mediated haemolytic anaemia (IMHA) is a" exact="common" post="haematological emergency and the incidence differs among breeds. It"/>
   <result pre="with gallbladder wall thickening and peritoneal effusion were the most" exact="common" post="abdominal imaging findings with bactibilia confirmed in one third"/>
   <result pre="acute phase protein serum amyloid A. In animals it is" exact="common" post="in chickens and cheetahs kept in captivity. Latest studies"/>
   <result pre="are rarely affected by systemic AA‐amyloidosis. Whether systemic AA‐amyloidosis is" exact="common" post="in domestic shorthair cats living in shelters and shedding"/>
   <result pre="Data collected for analysis included breed, sex, age, feline immunodeficiency" exact="virus" post="(FIV) and feline leukemia virus (FeLV) status, serum creatinine"/>
   <result pre="breed, sex, age, feline immunodeficiency virus (FIV) and feline leukemia" exact="virus" post="(FeLV) status, serum creatinine concentration, urine protein‐to‐creatinine (UPC) ratio"/>
   <result pre="0.042). In conclusion, MGN and MPGN were the two most" exact="common" post="morphological diagnoses of ICGN in cats, but clinical and"/>
   <result pre="other conflicts of interest. ESVNU‐O‐7 Prognostic factors in dogs with" exact="common" post="causes of proteinuria F. Baumgartner, F. Boretti, B. Gerber"/>
   <result pre="2University of Padova, Padova, Italy Feline parvovirus (FPV) is a" exact="common" post="infectious agent and can be lethal. The aim of"/>
   <result pre="of New South Wales, Sydney, Australia Feline caliciviruses (FCV) are" exact="common" post="feline pathogens causing &quot;flu&quot;‐like signs. Rarely, FCVs cause virulent"/>
   <result pre="performed on residual diagnostic oropharyngeal swabs and/or necropsy tissue. One" exact="virus" post="from each outbreak was tested in plaque reduction assays"/>
   <result pre="7, 28, FCV antibodies were determined in leftover samples by" exact="virus" post="neutralization (VN) using isolate KS20, and by p66 antigen"/>
   <result pre="United States of America Feline coronavirus (FCoV) infection is very" exact="common" post="in multi‐cat households. It has been proposed that cats"/>
   <result pre="positive correlation between height of antibody titre and mean faecal" exact="virus" post="load (Spearman r = 0.3394; P = 0.0035). Antibody titres"/>
   <result pre="(Mann‐Whitney U test P = 0.0026) and significantly higher mean faecal" exact="virus" post="loads (Mann‐Whitney U test P = 0.0383) than cats that"/>
   <result pre="shedding FCoV. Height of antibody titre was correlated to faecal" exact="virus" post="load. Chronic FCoV shedders had higher antibody titres and"/>
   <result pre="of 41 dogs were included in the study. The most" exact="common" post="breed was German shepherd dogs ( n = 24, 59%)."/>
   <result pre="was German shepherd dogs ( n = 24, 59%). The most" exact="common" post="organism cultured was A. terreus ( n = 24 out"/>
   <result pre="Medicine, Vetsuisse Faculty, Bern, Switzerland Overuse of antibiotics is a" exact="common" post="problem in veterinary medicine contributing to the development of"/>
   <result pre="[36‐47]) and after patient contact (37% [34‐41]), and was least" exact="common" post="prior to clean/aseptic procedures (12% [8‐15]). Veterinarians showed a"/>
   <result pre="and showed clonality (ST410, bla oxa181), suggesting transmission from a" exact="common" post="source rather than de novo selection. Persistence of ESBL‐producing"/>
   <result pre="Brno, Czech Republic Humoral hypercalcemia of malignancy (HHM) is a" exact="common" post="paraneoplastic syndrome in canine lymphoma and has always been"/>
   <result pre="Newmarket, United Kingdom Mast cell tumour (MCT) represents the most" exact="common" post="canine skin neoplasia and typically affects adult‐geriatric dogs (median"/>
   <result pre="and 11 females (6 entire, 5 neutered) and the most" exact="common" post="breeds were Labrador (5) and Golden Retriever (2). Of"/>
   <result pre="States of America Alimentary lymphoma is one of the most" exact="common" post="forms of neoplasia in feline patients. Chemotherapy has been"/>
   <result pre="la Universidad de Extremadura, Cáceres, Spain Cobalamin deficiency is a" exact="common" post="finding in dogs diagnosed with chronic enteropathy (CE) due"/>
   <result pre="function, routine screening of drug candidates for P‐gp transport is" exact="common" post="practice in human drug discovery. However, there is currently"/>
   <result pre="of Edinburgh, Midlothian, United Kingdom Chronic Enteropathies (CE) are a" exact="common" post="cause of morbidity in dogs. Chronic enteropathies are diagnosed"/>
   <result pre="i Portoni Rossi, Zola Predosa, Italy Chronic enteropathies (CE) are" exact="common" post="cause for persistent or recurrent gastrointestinal signs in dogs."/>
   <result pre="Nantes‐Atlantic College, Nantes, France Inflammatory bowel disease (IBD) is a" exact="common" post="cause of chronic gastrointestinal disease in dogs. The current"/>
   <result pre="3University of Bologna, Bologna, Italy Atrial fibrillation (AF) is a" exact="common" post="canine supraventricular arrhythmia usually observed in large breed dogs"/>
   <result pre="Maisons‐Alfort, France Degenerative mitral valve disease (DMVD) is the most" exact="common" post="acquired heart disease in small‐sized dogs with a high"/>
   <result pre="that red blood cell abnormalities (acanthocytosis and schizocytosis) are very" exact="common" post="in dogs with congenital arterial stenosis, thus suggesting that"/>
   <result pre="rhythm patterning. This study sought to characterize LP patterns for" exact="common" post="rhythms of dogs. Twenty Holter recordings free from pathologic"/>
   <result pre="controlled by the pacemaker. Specific LP patterns were identified for" exact="common" post="cardiac rhythms in dogs which supports non‐random mechanisms for"/>
   <result pre="Envenomation by the European adder (v ipera berus), is a" exact="common" post="seasonal presentation in small animal practice in Norway. Cardiac"/>
   <result pre="study shows that raised cTnI concentration and ventricular arrhythmias are" exact="common" post="following vipera berus envenomation in dogs and highlights the"/>
   <result pre="Basildon, United Kingdom Acute myocardial infarction (AMI) is the most" exact="common" post="cause of human ischemic heart disease. Its pathogenesis involves"/>
   <result pre="either pituitary‐ or adrenal‐dependent HAC, equivocal adrenal asymmetry was a" exact="common" post="finding in dogs with HAC, occurring in 30 of"/>
   <result pre="France, 4Micen Vet, Creteil, France Cushing's disease (CD) is a" exact="common" post="canine endocrinopathy, due to a deregulated secretion of ACTH"/>
   <result pre="Poland In addition to hypophosphatemia, metabolic acidosis is the most" exact="common" post="complication of chronic kidney disease in cats. Using the"/>
   <result pre="of Camerino, Camerino, Italy Immune‐Mediated Hemolytic Anaemia (IMHA) is a" exact="common" post="hematological disorder in dogs. It can be primary or"/>
   <result pre="and mixed breed ( P &amp;lt; 0,01). Neoplasia was the most" exact="common" post="cause of death (30%), especially in Boxers and Bernese."/>
   <result pre="Charles and Spitz from cardiovascular diseases. Under 7 years, the most" exact="common" post="causes were trauma (15%) and infections (7%). Compared to"/>
   <result pre="Our study revealed that, in both CE:CN cohorts, uroliths were" exact="common" post="in the order of struvites, calcium oxalates, cystines and"/>
   <result pre="chronic kidney disease (CKD) is assumed to be the most" exact="common" post="cause of proteinuria in cats, few studies have been"/>
   <result pre="of significant proteinuria in this species. Severe hypertension is a" exact="common" post="finding, highlighting the relevance of SBP measurement in these"/>
   <result pre="in Portugal. This study suggests that CVBD are the most" exact="common" post="differential diagnosis of renal proteinuria in dogs from Lisbon."/>
   <result pre="cystitis. Disclosures No disclosures to report. ESVNU‐P‐6 Non‐symptomatic bacteriuria is" exact="common" post="in young female boxer dogs S. Pagnamenta 1, D."/>
   <result pre="(median 1.024 vs. 1.037). Bacterial colonization of the urine is" exact="common" post="in young female Boxer dogs. The significance of this"/>
   <result pre="43% symptoms had been present for over 3 months. The most" exact="common" post="clinical symptom was nasal discharge (87%), unilateral in 55%."/>
   <result pre="diagnosed late, when the nasopharynx is already affected. The most" exact="common" post="histological type is adenocarcinoma; benign neoplasia, which is rarely"/>
   <result pre="Veterinary School Hospital, Cambridge, United Kingdom Lymphoma is the most" exact="common" post="haematopoetic neoplasm in the canine population. Chemotherapy protocols, such"/>
   <result pre="These protocols routinely involve vincristine. Current literature reports the most" exact="common" post="vincristine induced toxicity to be gastrointestinal effects but also"/>
   <result pre="P = 0.0267) abnormalities, while dermatologic signs appear to be more" exact="common" post="in young dogs compared with old ones ( P"/>
   <result pre="co‐infected by different filarial worm species and/or other vector‐borne pathogens" exact="common" post="in Southern Italy, n. 74 dogs showed A. reconditum"/>
   <result pre="in the treatment of cats naturally infected with feline immunodeficiency" exact="virus" post="(FiV) O. Sarpataki, A.R. Codea, I. Marcus, M. Cenariu,"/>
   <result pre="B. Sevastre Faculty of Veterinary Medicine, Cluj‐Napoca, Romania Feline immunodeficiency" exact="virus" post="(FiV) is one the most common infectious agents of"/>
   <result pre="Cluj‐Napoca, Romania Feline immunodeficiency virus (FiV) is one the most" exact="common" post="infectious agents of cats. FIV is a lentivirus that"/>
   <result pre="is a lentivirus that shares many properties with human immunodeficiency" exact="virus" post="(HIV), can cause an acquired immune deficiency syndrome (AIDS)"/>
   <result pre="in the treatment of cats naturally infected with feline immunodeficiency" exact="virus" post="(FiV). Cats presenting symptoms of recurrent infections (sinusitis, stomatitis)"/>
   <result pre="in the treatment of cats naturally infected with feline immunodeficiency" exact="virus" post="(FiV) and has no side effects on bone marrow"/>
   <result pre="States of America Canine Lyme borreliosis (LB) is a disease" exact="common" post="and well‐documented in the northeastern and midwestern parts of"/>
   <result pre="(21/39) had received antibiotic therapy prior to referral. The most" exact="common" post="presenting clinicopathological abnormalities of positive cases were increased hepatic"/>
   <result pre="X el Sabio, Madrid, Spain Urinary tract infections (UTIs) are" exact="common" post="in dogs but appropriate use of antimicrobial drugs is"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="./PMC6981968/results/search/virus_topics/results.xml">
   <result pre="MERS-CoV in Korea. Individuals who had been exposed to the" exact="virus" post="or in contact with either MERS-CoV patients or those"/>
   <result pre="to visit hospitals as they were afraid of contracting the" exact="virus" post="[ 2]. Therefore, the way citizens had stayed vigilant"/>
   <result pre="the way citizens had stayed vigilant not to catch the" exact="virus" post="was likely to be strengthened after the disclosure of"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="./PMC7000305/results/search/virus_topics/results.xml">
   <result pre="We also looked at the impact of medication history on" exact="virus" post="transmission. Method We included subjects with suspected MERS-CoV infection"/>
   <result pre="the likelihood of the infection. Conclusions MERS-Cov infection is more" exact="common" post="in male, advanced age and diabetes. No medications were"/>
   <result pre="where dromedary camels are a major reservoir host for this" exact="virus" post="or by a human to the human transmission which"/>
   <result pre="confirmation among suspected cases and impact on medications history on" exact="virus" post="transmission. 2 Material and methods 2.1 Study population Subjects"/>
   <result pre="of the confirmed cases were male (62%). More comorbidities are" exact="common" post="among the confirmed group including hypertension and diabetes compared"/>
   <result pre="and the blockage of this enzyme may interfere with the" exact="virus" post="transmission. In a similar study looked at the demographics"/>
   <result pre="MERS infection, many studies suggested that the infection is more" exact="common" post="in patients with comorbidities, primarily diabetes, and chronic kidney"/>
   <result pre="reported in the study. 5 Conclusion MERS-Cov infection is more" exact="common" post="in male, advanced age and diabetes. No medications were"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="./PMC7006675/results/search/virus_topics/results.xml">
   <result pre="respiratory disease in humans. The MERS-CoV spike (S) glycoprotein mediates" exact="viral entry" post="into target cells. For this, MERS-CoV S engages the"/>
   <result pre="the context of authentic MERS-CoV and were found to attenuate" exact="viral replication." post="Collectively, we identified naturally-occurring polymorphisms in DPP4 that negatively"/>
   <result pre="spike (S) glycoprotein, a type-I transmembrane protein embedded in the" exact="viral envelope." post="For host cell entry, the surface unit, S1, of"/>
   <result pre="that certain polymorphisms in DPP4 reduced MERS-CoV S binding and" exact="viral entry" post="triggered the question whether residues in MERS-CoV S that"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="./PMC7017508/results/search/virus_topics/results.xml">
   <result pre="in vitro macrolide sensitivity tests. Results MP and respiratory syncytial" exact="virus" post="(RSV) were the two most commonly identified pathogens of"/>
   <result pre="In children &amp;lt; 2 years of age, RSV (34.0%) was the most" exact="common" post="cause of CAP, followed by MP (9.4%); however, MP"/>
   <result pre="CAP, followed by MP (9.4%); however, MP was the most" exact="common" post="cause of CAP in children aged 2–18 years of age"/>
   <result pre="to CAP and improve pediatric health. Keywords Children Pneumonia Respiratory" exact="virus" post="Mycoplasma pneumoniae Macrolide- refractory Macrolide-sensitive Macrolide less-effective Funding Korea"/>
   <result pre="However, comprehensive studies on these topics are scarce. The most" exact="common" post="causes of pediatric CAP in high-income countries, which differ"/>
   <result pre="children underwent real-time polymerase chain reaction (RT-PCR) analyses for respiratory" exact="virus" post="( n = 30,994) or MP ( n = 9197), or underwent serology"/>
   <result pre="viruses were as follows: adenovirus (AdV), human rhinovirus (HRV), influenza" exact="virus" post="(FLU), parainfluenza virus (PIV), human metapneumovirus (HMPV), respiratory syncytial"/>
   <result pre="follows: adenovirus (AdV), human rhinovirus (HRV), influenza virus (FLU), parainfluenza" exact="virus" post="(PIV), human metapneumovirus (HMPV), respiratory syncytial virus (RSV), bocavirus"/>
   <result pre="virus (FLU), parainfluenza virus (PIV), human metapneumovirus (HMPV), respiratory syncytial" exact="virus" post="(RSV), bocavirus (BoV), and human coronavirus (HCoV). RT-PCR was"/>
   <result pre="number of children hospitalized with CAP due to various respiratory" exact="virus" post="infections was highest in 2015, with similar seasonal and"/>
   <result pre="October to November in each year (Fig. 1). The most" exact="common" post="clinical phenotype of MP pneumonia was MSMP, followed by"/>
   <result pre="older than 2 years of age, MP (45.3%) was the most" exact="common" post="cause of CAP, whereas 9.4% of children younger than"/>
   <result pre="groups in children hospitalized due to community-acquired pneumonia Detected respiratory" exact="virus" post="&amp;lt; 2 years, No. (%) 2–4 years, No. (%) 5–11 years, No. (%)"/>
   <result pre="750 (7.7) 112 (1.9) 45 (2.3) 1956 (6.3) Respiratory syncytial" exact="virus" post="4600 (34.0) 1451 (14.9) 194 (3.3) 59 (3.0) 6304"/>
   <result pre="(5.7) 749 (12.9) 177 (9.1) 1613 (5.2) Neither MP nor" exact="virus" post="identified 1997 (14.8) 1529 (15.7) 906 (15.6) 484 (24.8)"/>
   <result pre="1529 (15.7) 906 (15.6) 484 (24.8) 4916 (15.9) Only respiratory" exact="virus" post="detection 10,253 (75.8) 4660 (48.0) 1421 (24.5) 561 (28.8)"/>
   <result pre="pneumonia Variables only MP 1 ( n = 7455) MP coinfected with" exact="virus" post="2 ( n = 1728) Adenovirus 3 ( n = 680) Influenza virus"/>
   <result pre="with virus 2 ( n = 1728) Adenovirus 3 ( n = 680) Influenza" exact="virus" post="4 ( n = 1491) Metapneumovirus 5 ( n = 1287) RSV 6"/>
   <result pre="to 2015 in a nationwide retrospective cohort study. The most" exact="common" post="causes of hospitalization due to pediatric CAP were MP"/>
   <result pre="children less than 2 years of age, RSV was the most" exact="common" post="cause of pediatric CAP requiring hospitalization, whereas the most"/>
   <result pre="common cause of pediatric CAP requiring hospitalization, whereas the most" exact="common" post="cause was MP in children older than 2 years as"/>
   <result pre="the present study, we found that RSV was the most" exact="common" post="cause of CAP in children younger than 2 years of"/>
   <result pre="been misclassified into the &quot;no MP pneumonia and no respiratory" exact="virus" post="detection&quot; group due to a sampling error, including inappropriate"/>
   <result pre="Throughout the study period, MP and RSV were the most" exact="common" post="causes of CAP, with cyclic peaks in specific seasons."/>
   <result pre="AdV Adenovirus BoV Bocavirus CAP Community acquired pneumonia FLU Influenza" exact="virus" post="HCoV Human coronavirus HMPV Human metapneumovirus HRV Human rhinovirus"/>
   <result pre="MRMP Macrolide-refractory Mycoplasma pneumoniae MSMP Macrolide-sensitive Mycoplasma pneumoniae PIV Parainfluenza" exact="virus" post="RSV Respiratory syncytial virus RT-PCR Real-time polymerase chain reaction"/>
   <result pre="MSMP Macrolide-sensitive Mycoplasma pneumoniae PIV Parainfluenza virus RSV Respiratory syncytial" exact="virus" post="RT-PCR Real-time polymerase chain reaction Publisher’s Note Springer Nature"/>
   <result pre="estimates of acute lower respiratory infections due to respiratory syncytial" exact="virus" post="in young children in 2015: a systematic review and"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="./PMC7019290/results/search/virus_topics/results.xml">
   <result pre="other virus not classified into the first four categories (e.g.," exact="mycovirus" post="and archaeal virus etc.), virus with multiple hosts, and"/>
   <result pre="avian and swine influenza, and are mostly respiratory related, although" exact="viral shedding" post="of MERS coronavirus was also reported in camel and"/>
   <result pre="Viruses 2017 9 48 10.3390/v9030048 142. Simmonds P. Methods for" exact="virus classification" post="and the challenge of incorporating metagenomic sequence data J."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="./PMC7028525/results/search/virus_topics/results.xml">
   <result pre=". 2010 Fatal lower respiratory tract disease with human corona" exact="virus" post="NL63 in an adult haematopoietic cell transplant recipient ."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="./PMC7029452/results/search/virus_topics/results.xml">
   <result pre="transmission was observed early after the emergence of this new" exact="virus" post="in China and abroad, including family clusters and healthcare"/>
   <result pre="originating from imported cases and subsequently delay propagation of the" exact="virus" post="in the general population. This allows our healthcare system"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="./PMC7029759/results/search/virus_topics/results.xml">
   <result pre="small molecule drugs that could inhibit different aspects of the" exact="viral life cycle," post="ultimately inhibiting replication. Two classes of potential targets are"/>
   <result pre="of the biologic into tissues to more effectively bind to" exact="viral entry" post="receptors 45 . In regards to the outbreak situation"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="./PMC7033854/results/search/virus_topics/results.xml">
   <result pre="included in this test are as follows; adenovirus, rhinovirus, influenza" exact="virus" post="A/B, respiratory syncytial virus A/B, metapneumovirus, bocavirus, coronavirus, and"/>
   <result pre="are as follows; adenovirus, rhinovirus, influenza virus A/B, respiratory syncytial" exact="virus" post="A/B, metapneumovirus, bocavirus, coronavirus, and parainfluenza virus 1/2/3. All"/>
   <result pre="A/B, respiratory syncytial virus A/B, metapneumovirus, bocavirus, coronavirus, and parainfluenza" exact="virus" post="1/2/3. All patients were given chest X-rays and/or high"/>
   <result pre="in the Adv patients P &amp;lt;  0.001), while leukocytosis was more" exact="common" post="in the Non-Adv group patients ( P = 0.035). The levels"/>
   <result pre="NA   Rhinovirus 5 (7.5) 18 (9.8) 23 (9.2)   Influenza A/B" exact="virus" post="4 (6.0) 22 (12.0) 26 (10.4)   HMPV (−) 1"/>
   <result pre="1 (0.4)   RSV 1 (1.5) 3 (1.6) 4 (1.6)   Parainfluenza" exact="virus" post="1 (1.5) 3 (1.6) 4 (1.6)  Bacterial etiology ["/>
   <result pre="  Rhinovirus plus H.pneumoniae (−) 22 (12.0) 22 (8.8)   Influenza A/B" exact="virus" post="plus S.pneumoniae 1 (1.5) 6 (3.3) 7 (2.8)   Influenza"/>
   <result pre="plus S.pneumoniae 1 (1.5) 6 (3.3) 7 (2.8)   Influenza A/B" exact="virus" post="plus H.influenzae (−) 2 (1.1) 2 (0.8)   RSV plus"/>
   <result pre="coinfections with viruses, such as rhinovirus ( n = 5), influenza A" exact="virus" post="( n = 4), respiratory syncytial virus ( n = 1), and parainfluenza"/>
   <result pre="rhinovirus ( n = 5), influenza A virus ( n = 4), respiratory syncytial" exact="virus" post="( n = 1), and parainfluenza virus ( n = 1). Bacteria or"/>
   <result pre="virus ( n = 4), respiratory syncytial virus ( n = 1), and parainfluenza" exact="virus" post="( n = 1). Bacteria or combined etiologies were more common"/>
   <result pre="parainfluenza virus ( n = 1). Bacteria or combined etiologies were more" exact="common" post="in the Non-Adv group patients. Rhinovirus (40/184, 21.7%) was"/>
   <result pre="as the pathogen in the Non-Adv group patients. The most" exact="common" post="bacterial pathogens were Streptococcus pneumoniae in the Adv group"/>
   <result pre="influenzae in the Non-Adv group patients (52/184, 28.3%). The most" exact="common" post="radiological feature was ground-glass opacity with consolidation in the"/>
   <result pre="vs. 72.7%), however multilobar (≥ 3 lobes) involvement was more" exact="common" post="in the Non-Adv group (9.0 vs. 22.3%, P = 0.015). The"/>
   <result pre="pneumonia acAdv defined that CAP patients with adenovirus combined other" exact="virus" post="or bacteria as identified pathogen; bOAIP defined that CAP"/>
   <result pre="follows: a 3rd generation cephalosporin plus azithromycin was the most" exact="common" post="regimen ( n = 243, 96.8%), followed by piperacillin/tazobactam plus respiratory"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="./PMC7034298/results/search/virus_topics/results.xml">
   <result pre="recorded Alive P20 ( 6) 11 months Candida, BCGitis, rota" exact="virus" post="Yes Not recorded Unrelated Cord blood Not recorded MAC"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="./PMC7041086/results/search/virus_topics/results.xml">
   <result pre="remains controversial, depending on the definition of respiratory infection, the" exact="virus" post="panel studied, the time limit between VRTI and spirometric"/>
   <result pre="bacterial infections Microbiology findings Picornavirus was the most frequently detected" exact="virus" post="in the VIG ( n = 21), followed by parainfluenzae virus"/>
   <result pre="detected virus in the VIG ( n = 21), followed by parainfluenzae" exact="virus" post="( n = 13), and syncytial respiratory virus ( n = 10) (Table"/>
   <result pre="n = 21), followed by parainfluenzae virus ( n = 13), and syncytial respiratory" exact="virus" post="( n = 10) (Table 3). Pseudomonas aeruginosa was the main"/>
   <result pre="and others (n = 2). Three patients had more than one detected" exact="virus" post="and eight patients had more than one detected bacteria."/>
   <result pre="While studies using cell cultures in their screening method report" exact="virus" post="detection rates in respiratory samples at around 8% ["/>
   <result pre="immunocompromised with more frequent sampling of patients including wide respiratory" exact="virus" post="detection by molecular techniques and to strengthen spirometric controls"/>
   <result pre="Fung J Kusne S The pathogenesis and management of influenza" exact="virus" post="infection in organ transplant recipients Transpl Infect Dis 2002"/>
   <result pre="E71 10.1111/ctr.12054 22. Fisher CE Mohanakumar T Limaye AP Respiratory" exact="virus" post="infections and chronic lung allograft dysfunction: assessment of virology"/>
   <result pre="Edelman J Kirby KA Leisenring WM et al. Symptomatic respiratory" exact="virus" post="infection and chronic lung allograft dysfunction Clin Infect Dis"/>
   <result pre="Keenan R Zeevi A et al. The epidemiology of parainfluenza" exact="virus" post="infection in lung transplant recipients Clin Infect Dis 2001"/>
   <result pre="Sinha T Lisle C et al. Development of a respiratory" exact="virus" post="panel test for detection of twenty human respiratory viruses"/>
   <result pre="the detection of respiratory viral infections: evaluation of xTAG respiratory" exact="virus" post="panel fast assay, RespiFinder 19 assay and RespiFinder SMART"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="./PMC7046816/results/search/virus_topics/results.xml">
   <result pre="gene-based phylogeny of infectious bronchitis virus: an attempt to harmonize" exact="virus classification" post=". Infect Genet Evol 39: 349– 364. doi: 10.1016/j.meegid.2016.02.015"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="./PMC7047369/results/search/virus_topics/results.xml">
   <result pre="do we know so far about its clinical presentation? The" exact="virus" post="responsible for COVID-19, SARS-CoV-2, is in the species SARS-like"/>
   <result pre="It is almost certainly a descendant from a bat corona" exact="virus" post="of which there are many. The closest is a"/>
   <result pre="virus of which there are many. The closest is a" exact="virus" post="that originated from the Rhinolophus bat which is &amp;gt; 96%"/>
   <result pre="Health Organization (WHO) so concerned about it? As a novel" exact="virus" post="newly emerged in humans, the world’s population is completely"/>
   <result pre="still valid: to brace for the first wave as the" exact="virus" post="reaches a completely naïve population and to make maximum"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="./PMC7047374/results/search/virus_topics/results.xml">
   <result pre="Organization, a novel coronavirus (2019-nCoV) was identified as the causative" exact="virus" post="of Wuhan pneumonia of unknown etiology by Chinese authorities"/>
   <result pre="unknown etiology by Chinese authorities on 7 January, 2020. The" exact="virus" post="was named as severe acute respiratory syndrome coronavirus 2"/>
   <result pre="Viruses on 11 February, 2020, was identified as the causative" exact="virus" post="by Chinese authorities on 7 January [ 1]. It"/>
   <result pre="on 7 January [ 1]. It is reported that the" exact="virus" post="might be bat origin [ 2], and the transmission"/>
   <result pre="be bat origin [ 2], and the transmission of the" exact="virus" post="might related to a seafood market (Huanan Seafood Wholesale"/>
   <result pre="on 19 January, 2020 [ 12]. We assumed that the" exact="virus" post="transmitted among the bats, and then transmitted to unknown"/>
   <result pre="symptomatic infected people and asymptomatic infected people could export the" exact="virus" post="into W with the rate of μ P and"/>
   <result pre="although this assumption might occur in a low probability. The" exact="virus" post="in W will subsequently leave the W compartment at"/>
   <result pre="A P to W 1/ ε The lifetime of the" exact="virus" post="in W δ P The proportion of asymptomatic infection"/>
   <result pre="of the simulation, we assumed that the prevalence of the" exact="virus" post="in the market was 1/100000. Since the SARS-CoV-2 is"/>
   <result pre="there was no data of the initial prevalence of the" exact="virus" post="in the seafood market, we assumed the initial value"/>
   <result pre="travel to Wuhan City), the estimation of importation of the" exact="virus" post="might not be correct. All these limitations will lead"/>
   <result pre="Zhang X Zhao J et al. Risk of imported Ebola" exact="virus" post="disease in China Travel Med Infect Dis 2014 12"/>
   <result pre="Z Modeling the transmission of Middle East respirator syndrome Corona" exact="virus" post="in the Republic of Korea PLoS One 2015 10"/>
  </snippets>
 </snippetsTree>
</projectSnippetsTree>
